{
  "_metadata": {
    "_generation_timestamp": "2022-09-09 00:53:07.586366Z",
    "title": "TMF Reference Model",
    "version": "3.2.1",
    "version_date": "2021-03-01"
  },
  "artifacts": {
    "_count": 250,
    "items": [
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.01",
        "Artifact Location": [],
        "Artifact name": "Trial Master File Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe how records for the trial will be managed and stored during and after the trial, including study-specific processes and documentation for archiving and destruction. To include TMF filing structure to be used. May include TMF content list, filing structure and chain of custody records. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "ICH Code": "5.5.7",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Document Transfer Documentation",
          "Evidence of Quality Review",
          "Request to Lock TMF",
          "Trial Master File Plan",
          "Trial Master File Index",
          "Trial Master File Report"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "1",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.02",
        "Artifact Location": [],
        "Artifact name": "Trial Management Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe overall strategy for timelines, management and conduct of the trial and typically makes reference to other artifacts. Artifact can include details on contingency plan covering details for site start up planning.",
        "ICH Code": "2.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Clinical Development Plan",
          "Project Management Plan",
          "Trial Management Plan"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "2",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.03",
        "Artifact Location": [],
        "Artifact name": "Quality Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the operational techniques and activities undertaken within the quality management system to verify that the requirements for quality of the trial-related activities have been fulfilled. Relevant parts may include, but not be limited to, a plan written for internal oversight of study quality management, an audit plan, data verification steps; also includes escalation in the event of a quality issue being identified and all corrective and preventative actions determined. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "ICH Code": "5.0999999999999996",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Quality Documentation",
          "Quality Plan",
          "Quality Report"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "3",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.04",
        "Artifact Location": [],
        "Artifact name": "List of SOPs Current During Trial",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document which standard operating procedures (SOPs) and which versions were in effect for the duration of the trial and trial-specific procedures created for the trial. To include sponsor and third party SOPs. This artifact does not include the SOPs themselves. May include SOP waivers to document and describe study-specific deviation from a named SOP or working procedure and the rationale for the deviation, when applicable.",
        "ICH Code": "5.1.1",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "List of SOPs Current During Trial",
          "SOP Waivers",
          "SOP Deviations"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "4",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.05",
        "Artifact Location": [],
        "Artifact name": "Operational Procedure Manual",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe trial-related processes not covered by formal standard operating procedures. Includes manuals given to sites for ISFs and vendor study-specific manuals as well as any study related tools provided to investigator sites not subject to IRB/IEC approval. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists.",
        "ICH Code": "5.1.1",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Operational Procedure Manual",
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "5",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.06",
        "Artifact Location": [],
        "Artifact name": "Recruitment Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the planned subject enrolment/recruitment goals during the trial, including contingency plans. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "ICH Code": "5.6",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Recruitment Plan",
          "Recruitment Progress"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment"
        },
        "Translation Required": [],
        "Unique ID Number": "6",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.07",
        "Artifact Location": [],
        "Artifact name": "Communication Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe communication strategy and plans between trial stakeholders, including communication escalation procedures/steps. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Communication Plan",
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "7",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.08",
        "Artifact Location": [],
        "Artifact name": "Monitoring Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe how monitoring will be implemented during the trial, including strategy for source data verification and risk based monitoring (if applicable). Artifact can include any trial level evidence of plan execution including, but not limited to: plan, reports, checklists, etc.  Note:  Indiviudal Monitoring Visit Reports are filed in zone 5",
        "ICH Code": [
          "5.18.3",
          "5.18.7"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Monitoring Plan",
          "Risk Based Monitoring Plan",
          "Risk Based Monitoring Evidence"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "8",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.09",
        "Artifact Location": [],
        "Artifact name": "Medical Monitoring Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe how medical surveillance of trial subjects will be assured during the trial. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "ICH Code": "5.16",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Medical Monitoring Plan",
          "Medical Contact Report",
          "Medical Monitoring Decisions"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "9",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.10",
        "Artifact Location": [],
        "Artifact name": "Publication Policy",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the policy for publishing the trial results if publication policy is not captured within the protocol.",
        "ICH Code": "6.15",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Publication Policy",
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "10",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.11",
        "Artifact Location": [],
        "Artifact name": "Debarment Statement",
        "Artifact name in v1.3 EDM Reference Model": "Debarment Certification",
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To verify whether the applicant or any of its principals is currently debarred, suspended, proposed for debarment, or declared ineligible to receive federal awards; whether within the past three years the applicant, or any of its principals, has been convicted of or had a civil judgment rendered against it for, or been indicted for, commission of fraud or certain criminal offenses; and whether the applicant has had any federal award terminated for cause or default in the past three years. Often part of the site qualification process, however, can account for situations which might arise during the course of the study, especially relevant for long-term trials.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Debarment Statement",
          "Restricted Party Lists"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "11",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.12",
        "Artifact Location": [],
        "Artifact name": "Trial Status Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Routine trial status progress report generated by the sponsor or 3rd Party and distributed to trial stakeholders.",
        "ICH Code": "5.18.4 (g)",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress",
          "Process Number": "21"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Trial Status Report",
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Date Generated"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "12",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.13",
        "Artifact Location": [],
        "Artifact name": "Investigator Newsletter",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To inform investigative staff of common implementation issues and of the progress of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress",
          "Process Number": "21"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Investigator Newsletter",
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "13",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.14",
        "Artifact Location": [],
        "Artifact name": "Audit Certificate",
        "Artifact name in v1.3 EDM Reference Model": "Audit Certificates Report",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation to confirm that an audit was performed (does not contain the audit report).",
        "ICH Code": "8.4.4",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Conduct Audit(s)",
          "Process Number": "27"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Audit Certificate",
          "List of Audits"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Issue Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "14",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.15",
        "Artifact Location": [],
        "Artifact name": "Filenote Master List",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide a consolidated list/index of file notes generated during the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress",
          "Process Number": "21"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote Master List",
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "15",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.16",
        "Artifact Location": [],
        "Artifact name": "Risk Management Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the potential hazards associated with the trial, including an assessment of the likelihood of those hazards occurring and resulting in harm. The Risk Management Plan is intended to include the risks to participant safety in relation to the IMP and all other risks related to the design and methods of the trial, including risks to participant safety and rights, as well as reliability of results. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Risk Management Plan",
          "Risk Assessment",
          "Risk Log"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "236",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.17",
        "Artifact Location": [],
        "Artifact name": "Vendor Management Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the overall management strategy for third party vendors used to conduct trial-related activities. May include assignment of responsibilities for third party vendor oversight, performance indicators, monitoring activities and schedules, issue escalation and resolution process, technology and documentation transfer and business continuity plan. Artifacts providing evidence of plan execution including, but not limited to: reports, checklists, etc. and other records demonstrating oversight of a specific third party vendor should be filed in the appropriate artifacts in Zone 09",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Vendor Management Plan",
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "237",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.18",
        "Artifact Location": [],
        "Artifact name": "Roles and Responsibility Matrix",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To identify range and distribution of tasks and responsibilities; may define internal assignment and all external parties; covers GCP as well as business process; often part of the Contractual Agreement (09.02.03).",
        "ICH Code": [
          "5.2.2",
          "5.7"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Roles and Responsibility Matrix",
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "181",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.19",
        "Artifact Location": [],
        "Artifact name": "Transfer of Regulatory Obligations",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To specify the transfer of regulatory obligations from sponsor to each Affiliate/CRO/Vendor and may include other agreements. A sponsor may transfer responsibility for any or all of the obligations set forth in this part to another entity. Any such transfer shall be described in writing. If not all obligations are transferred, the writing is required to describe each of the obligations being assumed by the alternate entity. If all obligations are transferred, a general statement that all obligations have been transferred is acceptable.",
        "ICH Code": [
          "5.2.2",
          "5.7"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Transfer of Regulatory Obligations",
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "247",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.01.20",
        "Artifact Location": [],
        "Artifact name": "Operational Oversight",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation to show evidence of sponsor oversight of study, as well as any key decisions taken and the supporting rationale. Records demonstrating oversight of a specific third party should be filed in the appropriate artifacts in Zone 09.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Operational Oversight Plan",
          "Operational Oversight Evidence"
        ],
        "SOP Reference": [],
        "Section #": "1.01",
        "Section Name": "Trial Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "04 First Monitoring Visit"
        },
        "Translation Required": [],
        "Unique ID Number": "248",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.02.01",
        "Artifact Location": [],
        "Artifact name": "Trial Team Details",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To define trial roles, contact details and structure of the trial team - both sponsor and third parties; optionally this may include full and initials-only signature of all team members, role-to-role transition documents, organogram and/or team joining/leaving dates.",
        "ICH Code": [
          "2.8",
          "5.7"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / People",
          "Process Number": "7"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Trial Team Details",
          "Transition Evidence"
        ],
        "SOP Reference": [],
        "Section #": "1.02",
        "Section Name": "Trial Team",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "16",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.02.02",
        "Artifact Location": [],
        "Artifact name": "Trial Team Curriculum Vitae",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document qualifications and eligibility of sponsor trial team members. Documentation for third party trial team members should be filed in Zone 09.",
        "ICH Code": "2.8",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / People",
          "Process Number": "7"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Trial Team Curriculum Vitae",
        "SOP Reference": [],
        "Section #": "1.02",
        "Section Name": "Trial Team",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "17",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.03.01",
        "Artifact Location": [],
        "Artifact name": "Committee Process",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": [
          "To describe the purpose and mode of operation/manner of working of the Independent Trial Committee, which may be established by the sponsor to assess at intervals the progress of a clinical trial the safety data and the critical efficacy endpoints and to recommend to the sponsor whether to continue, modify or stop a trial. To describe in advance the decision-making process of the Committee that will evaluate key trial events (e.g. endpoints).",
          "Committee Types may include but not limited to: DMC, DSMB, National, Steering, Scientific, Internal DMC, Device, Dose Escalation, Safety Evaluation, Adjudication, Clinical Events Coordination. These may be used as sub-artifacts or metadata. Applies to all Committee artifacts"
        ],
        "ICH Code": "5.5.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Committees",
          "Process Number": "10"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Committee Charter",
          "Committee Process"
        ],
        "SOP Reference": [],
        "Section #": "1.03",
        "Section Name": "Trial Committee",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "18",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.03.02",
        "Artifact Location": [],
        "Artifact name": "Committee Member List",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the current composition of a trial committee. Can be part of the Charter.",
        "ICH Code": "5.5.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Committees",
          "Process Number": "10"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Member List",
        "SOP Reference": [],
        "Section #": "1.03",
        "Section Name": "Trial Committee",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "19",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.03.03",
        "Artifact Location": [],
        "Artifact name": "Committee Output",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any agreements or significant decisions regarding trial conduct, protocol violations, adverse event reporting, to include minutes, reports, notifications, recommendations from a trial committee. Can be applicable to interim and final analyses.",
        "ICH Code": [
          "1.25",
          "5.5.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Resolve Trial Issues",
          "Process Number": "31"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Committee Correspondence",
          "Committee Data Package",
          "Committee Minutes",
          "Committee Report"
        ],
        "SOP Reference": [],
        "Section #": "1.03",
        "Section Name": "Trial Committee",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "20",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.03.04",
        "Artifact Location": [],
        "Artifact name": "Committee Member Curriculum Vitae",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document qualifications and eligibility of the Committee Member to provide assessments, at set intervals, the progress of a clinical trial, of the safety data and the critical efficacy endpoints and to recommend to the sponsor whether to continue, modify or stop a trial. To include updates.",
        "ICH Code": "5.5.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Committees",
          "Process Number": "10"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Committee Member Curriculum Vitae",
          "Committee Member Medical License",
          "Committee Member Training Evidence"
        ],
        "SOP Reference": [],
        "Section #": "1.03",
        "Section Name": "Trial Committee",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "249",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.03.05",
        "Artifact Location": [],
        "Artifact name": "Committee Member Financial Disclosure Form",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To certify that no financial arrangements with a Committee Member have been made where study outcome could affect compensation; that the Committee Member has no proprietary interest in the tested product; that the Committee Member does not have a significant equity interest in the sponsor of the covered study, that the Committee Member has not received significant payments of other sorts; and/or disclosure of specified financial arrangements and any steps taken to minimize the potential for bias.",
        "ICH Code": "5.5.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Committees",
          "Process Number": "10"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Member Financial Disclosure Form",
        "SOP Reference": [],
        "Section #": "1.03",
        "Section Name": "Trial Committee",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "250",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.03.06",
        "Artifact Location": [],
        "Artifact name": "Committee Member Contract",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document agreement of trial requirements between sponsor or 3rd Party and Committee Member.",
        "ICH Code": "5.5.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Committees",
          "Process Number": "10"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Member Contract",
        "SOP Reference": [],
        "Section #": "1.03",
        "Section Name": "Trial Committee",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "251",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.03.07",
        "Artifact Location": [],
        "Artifact name": "Committee Member Confidentiality Disclosure Agreement",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "A document between the sponsor and the Committee Member that defines the terms and basic criteria to assure that the party (or parties) receiving confidential information will maintain confidentiality and will not use that information for any purpose other than that described in the Agreement.",
        "ICH Code": "5.5.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Committees",
          "Process Number": "10"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Member Confidentiality Disclosure Agreement",
        "SOP Reference": [],
        "Section #": "1.03",
        "Section Name": "Trial Committee",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "252",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.04.01",
        "Artifact Location": [],
        "Artifact name": "Kick-off Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation made available for attendees of the trial kick-off meeting, including attendance sheets. Does not include Investigator Meeting content.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress",
          "Process Number": "21"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Kick-off Meeting Agenda",
          "Kick-off Meeting Attendance Sheet",
          "Kick-off Meeting Presentation Materials",
          "Kick-off Meeting Minutes"
        ],
        "SOP Reference": [],
        "Section #": "1.04",
        "Section Name": "Meetings",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "24",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.04.02",
        "Artifact Location": [],
        "Artifact name": "Trial Team Training Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Trial-relevant training materials , including use of specialized systems.",
        "ICH Code": "5.4.1",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage People",
          "Process Number": "26"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Trial Team Training Material",
        "SOP Reference": [],
        "Section #": "1.04",
        "Section Name": "Meetings",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "25",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.04.03",
        "Artifact Location": [],
        "Artifact name": "Investigators Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation made available for attendees of the investigator meeting(s). Includes meeting minutes or questions and answers (Q&A), attendance sheets and any pre-meeting material.",
        "ICH Code": [
          "4.1.2",
          "4.2.4"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress",
          "Process Number": "21"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Investigators Meeting Agenda",
          "Investigators Meeting Attendance Sheet",
          "Investigators Meeting Minutes",
          "Investigators Meeting Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "1.04",
        "Section Name": "Meetings",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "26",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.04.04",
        "Artifact Location": [],
        "Artifact name": "Trial Team Evidence of Training",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document completion of study-specific trial team training, including certification or evidence of training (attendance sheets) . Includes EDC training. Does not include each individual's education, training and experience to perform his/her role.This should be doucmentated in the company learning management system.",
        "ICH Code": "2.8",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Committees",
          "Process Number": "10"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Trial Team Training Attendance Sheet",
          "Trial Team Training Certificate"
        ],
        "SOP Reference": [],
        "Section #": "1.04",
        "Section Name": "Meetings",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Training Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "253",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.05.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but are not limited to: letters, memo, electronic communications and faxes. Correspondence referring to general topics and/or topics across multiple zones may be filed with this zone",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress / Per content",
          "Process Number": "21 / Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "1.05",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "27",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.05.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "1.05",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "28",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.05.03",
        "Artifact Location": [],
        "Artifact name": "Other Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during any other internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Other Meeting Agenda",
          "Other Meeting Attendance Sheet",
          "Other Meeting Minutes",
          "Other Meeting Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "1.05",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "29",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "01.05.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone. Filenotes referencing general topics and/or topics across multiple zones may be  filed within this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "1.05",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "30",
        "Wet Ink Signature": [],
        "Zone #": "1",
        "Zone Name": "Trial Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.01.01",
        "Artifact Location": [],
        "Artifact name": "Investigator's Brochure",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide relevant and current clinical and non-clinical data on the investigational product(s) that is related to the study of the product(s) in human subjects. The Investigational Medicinal Product Brochure (IMPD) can additionally be filed here if held in the TMF.",
        "ICH Code": [
          "7.1",
          "8.2.1",
          "8.3.1"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Study Conduct",
          "Process Number": "2"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Investigator's Brochure",
          "Investigator's Brochure Addendum",
          "Investigator's Brochure Extension",
          "Investigator's Brochure Review and Approval",
          "Investigator's Brochure Summary of Changes",
          "Investigational Medicinal Product Documentation"
        ],
        "SOP Reference": [],
        "Section #": "2.01",
        "Section Name": "Product and Trial Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "31",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.01.02",
        "Artifact Location": [],
        "Artifact name": "Protocol",
        "Artifact name in v1.3 EDM Reference Model": "Full Protocol (CSR component)",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the objective(s), design, methodology, statistical considerations and organization of a trial. Usually also gives the background and rationale for the trial, but these could also be provided in other protocol referenced documents. Includes Special Protocols.",
        "ICH Code": [
          "1.44",
          "8.2.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Study Conduct",
          "Process Number": "2"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Protocol",
          "Protocol Review and Approval",
          "Clinical Investigation Plan (Devices)"
        ],
        "SOP Reference": [],
        "Section #": "2.01",
        "Section Name": "Product and Trial Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "32",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.01.03",
        "Artifact Location": [],
        "Artifact name": "Protocol Synopsis",
        "Artifact name in v1.3 EDM Reference Model": "Synopsis (CSR component)",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "A summary of the pertinent points of the protocol. A local language version may be translated from core (English) or produced in the country if required by local Regulatory Authorities or IRB/IEC",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Protocol Synopsis",
        "SOP Reference": [],
        "Section #": "2.01",
        "Section Name": "Product and Trial Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "33",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.01.04",
        "Artifact Location": [],
        "Artifact name": "Protocol Amendment",
        "Artifact name in v1.3 EDM Reference Model": "Protocol Amendment (CSR component)",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Subsequent versions of the original protocol as well as supporting documentation that may include description of change(s) to or formal clarification of a protocol. Includes justification for a non-substantial amendment, such as administrative changes",
        "ICH Code": [
          "1.45",
          "8.3.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Protocol Amendment",
          "Protocol Amendment Summary of Changes",
          "Protocol Amendment Review and Approval",
          "Protocol Amendment Synopsis",
          "Protocol Amendment  Administrative Changes",
          "Justification For a Non-Substantial Amendment"
        ],
        "SOP Reference": [],
        "Section #": "2.01",
        "Section Name": "Product and Trial Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "34",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.01.05",
        "Artifact Location": [],
        "Artifact name": "Financial Disclosure Summary",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Summary documentation of compliance with financial disclosure reporting requirements, per company and/or local government policies. May include summaries, lists, other reports. Not specifically intended for program level records such as Forms FDA 3455 or 3454.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / People",
          "Process Number": "7"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Financial Disclosure Summary",
        "SOP Reference": [],
        "Section #": "2.01",
        "Section Name": "Product and Trial Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "35",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.01.06",
        "Artifact Location": [],
        "Artifact name": "Insurance",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document that compensation to subject(s) for trial-related injury will be available. May include policy and certificates, terms and conditions. Certificate is core, policy is recommended.",
        "ICH Code": "8.2.5",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Insurance Policy",
          "Insurance Certificate"
        ],
        "SOP Reference": [],
        "Section #": "2.01",
        "Section Name": "Product and Trial Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Effective Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "36",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.01.07",
        "Artifact Location": [],
        "Artifact name": "Sample Case Report Form",
        "Artifact name in v1.3 EDM Reference Model": "Sample CRF/eCRF",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Blank forms / templates in paper form or e-Format to capture the data points of the protocol.",
        "ICH Code": [
          "8.2.2",
          "8.3.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Sample Case Report Form",
          "CRF Summary of Changes",
          "CRF Review and Approval"
        ],
        "SOP Reference": [],
        "Section #": "2.01",
        "Section Name": "Product and Trial Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "37",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.01.10",
        "Artifact Location": [],
        "Artifact name": "Report of Prior Investigations",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To include reports of all prior clinical, animal and laboratory testing of the device and shall be comprehensive and adequate to justify the proposed investigation. Can be in addition or instead of an Investigator Brochure for device trials.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Study Conduct",
          "Process Number": "2"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Report of Prior Investigations",
          "Report of Prior Investigations Addendum",
          "Report of Prior Investigations Summary of Changes",
          "Report of Prior Investigations Review and Approval"
        ],
        "SOP Reference": [],
        "Section #": "2.01",
        "Section Name": "Product and Trial Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "NO"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "239",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.01.11",
        "Artifact Location": [],
        "Artifact name": "Marketed Product Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Materials available in the legal pharmacologic description of a drug or device, subject to detailed regulatory specifications, including approved chemical and proprietary names, description and classification, clinical pharmacology, approved indications and usage, contraindications, warnings, precautions, adverse reactions, drug abuse and dependence information, over dosage discussion, dosage and administration, formulations and appropriate references.",
        "ICH Code": [
          "7.1",
          "8.2.1",
          "8.3.1"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Study Conduct",
          "Process Number": "2"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Package Insert",
          "Summary of Product Characteristics"
        ],
        "SOP Reference": [],
        "Section #": "2.01",
        "Section Name": "Product and Trial Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "254",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.02.01",
        "Artifact Location": [],
        "Artifact name": "Subject Diary",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document subject data captured by the subject and external to the CRF (blank forms / templates).",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Subject Diary",
          "Subject Diary Review and Approval",
          "Subject Diary Summary of Changes"
        ],
        "SOP Reference": [],
        "Section #": "2.02",
        "Section Name": "Subject Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "38",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.02.02",
        "Artifact Location": [],
        "Artifact name": "Subject Questionnaire",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To capture specific subject related information through a series of questions (blank forms / templates)",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Capture Subject Data",
          "Process Number": "3"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Subject Questionnaire",
          "Subject Questionnaire Review and Approval",
          "Subject Questionnaire Summary of Changes"
        ],
        "SOP Reference": [],
        "Section #": "2.02",
        "Section Name": "Subject Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "39",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.02.03",
        "Artifact Location": [],
        "Artifact name": "Informed Consent Form",
        "Artifact name in v1.3 EDM Reference Model": "Informed Consent",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document that the appropriate written information (content and wording) has been given to subjects regarding the trial to support their ability to give fully informed consent and to document their consent to trial participation in writing. If applicable, must also include the child assent form (blank model / template). Please note that core template is trial level, the country template is country level and the site template is at the site level",
        "ICH Code": [
          "8.2.3",
          "8.3.2",
          "8.3.12"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Recruit Subjects & Obtain Consent",
          "Process Number": "17"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Consent to Release Information or HIPAA / Privacy",
          "Informed Consent Form",
          "ICF Addendum",
          "ICF QC Checklist",
          "ICF Review and Approval",
          "ICF Summary of Changes"
        ],
        "SOP Reference": [],
        "Section #": "2.02",
        "Section Name": "Subject Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "40",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.02.04",
        "Artifact Location": [],
        "Artifact name": "Subject Information Sheet",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document information provided to subjects to support their decision about whether or not to participate in the trial.",
        "ICH Code": [
          "8.2.3",
          "8.3.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Subject Information Sheet",
          "Subject Information Sheet Addendum",
          "Subject Information Sheet Summary of Changes",
          "Subject Information Sheet Review and Approval"
        ],
        "SOP Reference": [],
        "Section #": "2.02",
        "Section Name": "Subject Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "41",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.02.05",
        "Artifact Location": [],
        "Artifact name": "Subject Participation Card",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To be provided to the subject to carry to document trial participation (blank template).",
        "ICH Code": [
          "8.2.3",
          "8.3.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Subject Participation Card",
          "Subject Participation Card Summary of Changes",
          "Subject Participation Card Review and Approval"
        ],
        "SOP Reference": [],
        "Section #": "2.02",
        "Section Name": "Subject Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "42",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.02.06",
        "Artifact Location": [],
        "Artifact name": "Advertisements for Subject Recruitment",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Materials used in clinical trial recruitment campaigns; approved by the IRB/IEC to ensure recruitment measures are appropriate and not coercive.",
        "ICH Code": [
          "8.2.3",
          "8.3.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Advertisements for Subject Recruitment",
          "Advertisements for Subject Recruitment Review and Approval"
        ],
        "SOP Reference": [],
        "Section #": "2.02",
        "Section Name": "Subject Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "43",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.02.07",
        "Artifact Location": [],
        "Artifact name": "Other Information Given to Subjects",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Materials provided to the subject to further assist with understanding the trial requirements or concepts; may include memory aids or retention materials.",
        "ICH Code": [
          "8.2.3",
          "8.3.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Recruit Subjects & Obtain Consent",
          "Process Number": "17"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Other Information Given to Subjects",
        "SOP Reference": [],
        "Section #": "2.02",
        "Section Name": "Subject Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "44",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.03.01",
        "Artifact Location": [],
        "Artifact name": "Clinical Study Report",
        "Artifact name in v1.3 EDM Reference Model": [
          "Legacy CSR",
          "Report Body"
        ],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe final or interim results and interpretation of trial of any therapeutic, prophylactic, or diagnostic agent conducted in human subjects, in which all Clinical Study Report components are included, such as the clinical and statistical description, analyses, data listings, CRFs and summaries.",
        "ICH Code": [
          "1.13",
          "8.4.8"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Report Data / Write Reports",
          "Process Number": "40"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Clinical Study Report",
          "Clinical Study Report Synopsis",
          "Interim Clinical Study Report",
          "Interim Clinical Study Report Synopsis",
          "Form FDA 3654 (devices)"
        ],
        "SOP Reference": [],
        "Section #": "2.0299999999999998",
        "Section Name": "Reports",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Report Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "45",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.03.02",
        "Artifact Location": [],
        "Artifact name": "Bioanalytical Report",
        "Artifact name in v1.3 EDM Reference Model": "Type of Clinical Report",
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To present & summarize the relevant top line findings of the bioanalytical aspects of the interim or final analysis and may include PK analysis or reports.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Final Data Analysis",
          "Process Number": "37"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Bioanalytical Report",
          "Pharmacokinetic Report"
        ],
        "SOP Reference": [],
        "Section #": "2.0299999999999998",
        "Section Name": "Reports",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Report Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "NO"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "47",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.04.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "2.04",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "48",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.04.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "2.04",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "49",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.04.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress",
          "Process Number": "21"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "2.04",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "50",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "02.04.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "2.04",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "51",
        "Wet Ink Signature": [],
        "Zone #": "2",
        "Zone Name": "Central Trial Documents"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.01.01",
        "Artifact Location": [],
        "Artifact name": "Regulatory Submission",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": [
          "A set of documents, along with required associated regulatory forms and correspondence, submitted to one or more regulatory agencies requesting approval to conduct the trial or for the purpose of notification, or requesting approval of changes to the trial documents or of any trial events that could adversely affect the safety of subjects, impact the conduct of the trial or alter the regulatory authority's approval/favorable opinion to continue the trial. Example Investigational New Drug Application (IND), Clinical Trial Application (CTA),  Investigational Device Exemption (IDE)",
          "The submitted documents such as Investigator Brochure, Informed Consent Forms, etc. may or may not be filed as a complete Dossier within this Artifact, this is dependent on SOPs within your Organization."
        ],
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Secure Ethical Approvals",
          "Process Number": "13"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Cover Letter",
          "List of Content Submitted",
          "Receipt of Acknowledgement",
          "Regulatory Submission",
          "Review and Approval of Regulatory Submission"
        ],
        "SOP Reference": [],
        "Section #": "3.01",
        "Section Name": "Trial Approval",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Submission Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "52",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.01.02",
        "Artifact Location": [],
        "Artifact name": "Regulatory Authority Decision",
        "Artifact name in v1.3 EDM Reference Model": "Letter of Authorization",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "A documented notification received from a regulatory authority stating that the Submission has been received and approved.",
        "ICH Code": [
          "8.2.9",
          "8.3.4"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Secure Regulatory Approval",
          "Process Number": "14"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Conditional Approval",
          "List of Content Approved",
          "Regulatory Authority Decision"
        ],
        "SOP Reference": [],
        "Section #": "3.01",
        "Section Name": "Trial Approval",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Approval Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "53",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.01.03",
        "Artifact Location": [],
        "Artifact name": "Notification of Regulatory Identification Number",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Document identifying unique Identification (ID) number used to uniquely identify the trial or the trial level in that region, assigned by a regulatory agency  e.g. EU = EudraCT Number, FDA = IND Number, US Device = IDE Number.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Regulatory Approval",
          "Process Number": "14"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Notification of Regulatory Identification Number",
        "SOP Reference": [],
        "Section #": "3.01",
        "Section Name": "Trial Approval",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Notification Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "54",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.01.04",
        "Artifact Location": [],
        "Artifact name": "Public Registration",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation related to registration of clinical trials in public registries such as ClinicalTrials.gov and to submission of results periodically during the study and at study completion.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Notify Regulatory Agency of Trial",
          "Process Number": "11"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Public Registration",
          "Receipt of Acknowledgement"
        ],
        "SOP Reference": [],
        "Section #": "3.01",
        "Section Name": "Trial Approval",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Registration Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "55",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.02.01",
        "Artifact Location": [],
        "Artifact name": "Import or Export License Application",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "An application made to one or more regulatory agencies requesting a license to import or export the investigational product and clinical supplies.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Ethical Approvals",
          "Process Number": "13"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Import License Application",
          "Export License Application"
        ],
        "SOP Reference": [],
        "Section #": "3.02",
        "Section Name": "Investigational Medicinal Product",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Application Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "56",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.02.02",
        "Artifact Location": [],
        "Artifact name": "Import or Export Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "A document issued by a national government authorizing the importation or exportation of certain goods into its territory.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Supplies",
          "Process Number": "6"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Import License",
          "Export License"
        ],
        "SOP Reference": [],
        "Section #": "3.02",
        "Section Name": "Investigational Medicinal Product",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Effective Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "57",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.03.01",
        "Artifact Location": [],
        "Artifact name": "Notification of Safety or Trial Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Notification to Regulatory Authorities of any trial events that could alter the regulatory authority's approval/favorable opinion to continue the trial. Notifications may include, but are not limited to: Quarterly line listings, suspected unexpected serious adverse reactions (SUSARs), Unexpected Serious Adverse Device Events (USADE), Council for International Organizations of Medical Sciences (CIOMS), MedWatch, Analysis of Similar Events, Serious Breaches, cover letters and/or country-specific reporting forms.",
        "ICH Code": "8.3.17",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
          "Process Number": "28"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Evidence of Distribution of Safety Information",
          "Evidence of Distribution of Trial Information",
          "Notification of Safety Information",
          "Notification of Trial Information"
        ],
        "SOP Reference": [],
        "Section #": "3.03",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Notification Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "58",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.03.02",
        "Artifact Location": [],
        "Artifact name": "Regulatory Progress Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Reports concerning trial conduct, progress and status that are required to be periodically submitted to relevant regulatory authorities. This artifact is not intended to include safety reports required by regulatory authorities (these are covered under artifact 03.03.01).",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Report Data / Provide Trial Updates",
          "Process Number": "39"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Regulatory Progress Report",
        "SOP Reference": [],
        "Section #": "3.03",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Submission Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "59",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.03.03",
        "Artifact Location": [],
        "Artifact name": "Regulatory Notification of Trial Termination",
        "Artifact name in v1.3 EDM Reference Model": "Notification of Discontinuation of Clinical Trial",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Document detailing the termination of a trial  whether upon completion or premature termination.",
        "ICH Code": "4.12, 5.21",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Close Site(s) / Notify Bodies",
          "Process Number": "32"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Regulatory Notification of Trial Termination",
        "SOP Reference": [],
        "Section #": "3.03",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Notification Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "60",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.04.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "3.04",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "61",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.04.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "3.04",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "62",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.04.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Regulatory Approval",
          "Process Number": "14"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "3.04",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "63",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "03.04.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Ethical Approvals",
          "Process Number": "13"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "3.04",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "64",
        "Wet Ink Signature": [],
        "Zone #": "3",
        "Zone Name": "Regulatory"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.01.01",
        "Artifact Location": [],
        "Artifact name": "IRB or IEC Submission",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Documents describing the trial or changes/updates to the trial submitted to an IRB/IEC for approval, including recruitment and education materials and responses to questions from IRB/IEC to support a submission. Intended to include a list of attachments or table of contents of submission dossier/package. The submitted study documents such as Investigator Brochure, Informed Consent Forms, etc. may or may not be filed as a complete Dossier within this Artifact.",
        "ICH Code": [
          "8.2.7",
          "8.3.3"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Secure Ethical Approvals",
          "Process Number": "13"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Acknowledgement of Submission Receipt",
          "IRB or IEC Submission",
          "Request for Additional Information",
          "Responses"
        ],
        "SOP Reference": [],
        "Section #": "4.01",
        "Section Name": "IRB or IEC Trial Approval",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Submission Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "65",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.01.02",
        "Artifact Location": [],
        "Artifact name": "IRB or IEC Decision",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation received from IRB/IEC in response to submission indicating decision of the trial and any specifications or modifications. Records referenced by the approval (such as a Protocol that has been approved) should be filed elsewhere in the TMF, as appropriate, as long as there is identification of the approved record within the IRB/IEC letter.",
        "ICH Code": [
          "8.2.7",
          "8.3.3"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Secure Ethical Approvals",
          "Process Number": "13"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IRB or IEC Approval",
          "IRB or IEC Conditional Approval",
          "IRB or IEC Decision",
          "IRB or IEC Rejection"
        ],
        "SOP Reference": [],
        "Section #": "4.01",
        "Section Name": "IRB or IEC Trial Approval",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Approval Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "66",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.01.03",
        "Artifact Location": [],
        "Artifact name": "IRB or IEC Composition",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation that the IRB/IEC consists of a reasonable number of members who collectively have the qualifications and experience to review and evaluate the science, medical aspects and ethics of the proposed trial.",
        "ICH Code": "8.2.8",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Secure Ethical Approvals",
          "Process Number": "13"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRB or IEC Composition",
        "SOP Reference": [],
        "Section #": "4.01",
        "Section Name": "IRB or IEC Trial Approval",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Effective Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "67",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.01.04",
        "Artifact Location": [],
        "Artifact name": "IRB or IEC Documentation of Non-Voting Status",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation verifying non-voting members of the IRB/IEC if the investigator or sub-investigator is on the IRB/IEC.",
        "ICH Code": "3.2.1",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Secure Ethical Approvals",
          "Process Number": "13"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRB or IEC Documentation of Non-Voting Status",
        "SOP Reference": [],
        "Section #": "4.01",
        "Section Name": "IRB or IEC Trial Approval",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "68",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.01.05",
        "Artifact Location": [],
        "Artifact name": "IRB or IEC Compliance Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation that the IRB/IEC is performing its function according to written operating procedures and is in compliance with GCP and applicable regulatory requirements.",
        "ICH Code": [
          "3.2.2",
          "3.4"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Secure Other Approvals",
          "Process Number": "15"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRB or IEC Compliance Documentation",
        "SOP Reference": [],
        "Section #": "4.01",
        "Section Name": "IRB or IEC Trial Approval",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "69",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.02.01",
        "Artifact Location": [],
        "Artifact name": "Other Submissions",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": [
          "A set of documents describing the trial or changes/updates to the trial submitted to a committee other than the IRB/IEC for approval. To include: Submissions and Correspondence",
          "The submitted study documents such as Investigator Brochure, Informed Consent Forms, etc. may or may not be filed as a complete dossier within this artifact."
        ],
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Secure Other Approvals",
          "Process Number": "15"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Other Approval Committee Submissions",
        "SOP Reference": [],
        "Section #": "4.0199999999999996",
        "Section Name": "Other Committees",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Submission Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "70",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.02.02",
        "Artifact Location": [],
        "Artifact name": "Other Approvals",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": [
          "Approval documentation received from a committee other than the IRB/IEC in response to submission indicating approval/acknowledgement of trial specifications or modifications. To include: Submissions and Correspondence",
          "Records referenced by the approval (such as a Protocol that has been approved) should be filed elsewhere in the TMF, as appropriate, as long as there is identification of the approved record within the committee letter or acknowledgement."
        ],
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Other Approvals",
          "Process Number": "15"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Other Approval Committee Decisions",
        "SOP Reference": [],
        "Section #": "4.0199999999999996",
        "Section Name": "Other Committees",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Approval Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "71",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.03.01",
        "Artifact Location": [],
        "Artifact name": "Notification to IRB or IEC of Safety Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To assure the IRB/IEC are promptly notified of all findings (new, important information on serious adverse events and or safety concerns) that could adversely affect the safety of subjects, impact the conduct of the trial or alter the IRB/IEC's approval/favorable opinion to continue the trial.  Notifications/Communication may include but are not limited to - periodic safety line listings, USADEs, SUSARs, CIOMS, MedWatch, Analysis of Similar Events, cover letters and/or IRB/IEC-specific reporting forms. The records referenced in these notifications may be filed as appropriate in Zone 07.",
        "ICH Code": [
          "8.3.17",
          "4.3.1",
          "4.4.3",
          "4.10.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
          "Process Number": "28"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Evidence of Distribution of Safety Information",
          "Notification to IRB or IEC of Safety Information"
        ],
        "SOP Reference": [],
        "Section #": "4.03",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Notification Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "72",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.03.02",
        "Artifact Location": [],
        "Artifact name": "IRB or IEC Progress Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "06 Annual IRB / IEC Renewal",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Regular reports concerning trial conduct, other than safety reports, issued to the IRB/IEC by the sponsor/3rd Party and/or investigator.",
        "ICH Code": [
          "8.3.19",
          "3.1.4",
          "3.3.8",
          "4.4",
          "4.52",
          "4.54",
          "4.10.1",
          "4.10.2",
          "8.4.7"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Report Data / Provide Trial Updates",
          "Process Number": "39"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Evidence of Distribution of Progress Report",
          "IRB or IEC Progress Report"
        ],
        "SOP Reference": [],
        "Section #": "4.03",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "06 Annual IRB / IEC Renewal",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Submission Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "73",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.03.03",
        "Artifact Location": [],
        "Artifact name": "IRB or IEC Notification of Trial Termination",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Document detailing the termination of a trial  whether upon completion or premature termination.",
        "ICH Code": [
          "4.13",
          "4.12",
          "5.21"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Close Site(s) / Notify Bodies",
          "Process Number": "32"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IRB or IEC Notification of Site Closure",
          "IRB or IEC Notification of Trial Termination"
        ],
        "SOP Reference": [],
        "Section #": "4.03",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Submission Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "74",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.04.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "4.04",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "75",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.04.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress",
          "Process Number": "21"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "4.04",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "76",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.04.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Ethical Approvals",
          "Process Number": "13"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "4.04",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "77",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "04.04.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "4.04",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "78",
        "Wet Ink Signature": [],
        "Zone #": "4",
        "Zone Name": "IRB or IEC and other Approvals"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.01.01",
        "Artifact Location": [],
        "Artifact name": "Site Contact Details",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document contact information for primary points of contact at the site (e.g. Principal Investigator, Institution Name, Trial Coordinator, Contracts Person, etc.).",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / People",
          "Process Number": "7"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Site Contact Details",
        "SOP Reference": [],
        "Section #": "5.01",
        "Section Name": "Site Selection",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "79",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.01.02",
        "Artifact Location": [],
        "Artifact name": "Confidentiality Agreement",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "A document between the sponsor and an outside party (Investigator or Institution) that defines the terms and basic criteria to assure that the party (or parties) receiving confidential information will maintain confidentiality and will not use that information for any purpose other than that described in the Agreement. May also be present in the Clinical Trial Agreement",
        "ICH Code": "1.1599999999999999",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / People",
          "Process Number": "7"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Confidentiality Agreement",
        "SOP Reference": [],
        "Section #": "5.01",
        "Section Name": "Site Selection",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "80",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.01.03",
        "Artifact Location": [],
        "Artifact name": "Feasibility Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document site feasibility for the given protocol.",
        "ICH Code": "5.6",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Feasibility & Site Evaluation",
          "Process Number": "5"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Feasibility Documentation",
          "Feasibility Questionnaire",
          "Site Selection Documentation",
          "Technical Capabilities Questionnaire"
        ],
        "SOP Reference": [],
        "Section #": "5.01",
        "Section Name": "Site Selection",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "81",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.01.04",
        "Artifact Location": [],
        "Artifact name": "Pre Trial Monitoring Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document onsite visit to determine qualification of site to participate in the trial. For example may include the following documentation: EDC qualification, Confirmation Letters / Emails, site profile form.",
        "ICH Code": [
          "8.2.19",
          "5.6"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Pre Trial Monitoring Report",
          "Pre Trial Visit Confirmation Letter",
          "Pre Trial Visit Follow Up Letter",
          "Pre Trial Visit Waiver",
          "Site Selection Letter"
        ],
        "SOP Reference": [],
        "Section #": "5.01",
        "Section Name": "Site Selection",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Visit Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "82",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.01.05",
        "Artifact Location": [],
        "Artifact name": "Sites Evaluated but not Selected",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation related to sites evaluated but not selected for the trial.",
        "ICH Code": "5.6",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / People",
          "Process Number": "7"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Sites Evaluated but not Selected",
        "SOP Reference": [],
        "Section #": "5.01",
        "Section Name": "Site Selection",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "83",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.01",
        "Artifact Location": [],
        "Artifact name": "Acceptance of Investigator Brochure",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document that relevant and current scientific information about the investigational product has been provided to the investigator.",
        "ICH Code": [
          "8.2.1",
          "8.3.1"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Acceptance of Investigator Brochure",
          "Evidence of Investigator Brochure Distribution",
          "Evidence of Reference Safety Information Distribution"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "84",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.02",
        "Artifact Location": [],
        "Artifact name": "Protocol Signature Page",
        "Artifact name in v1.3 EDM Reference Model": "Signature Page (Protocol component)",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document investigator and sponsor agreement to the protocol.",
        "ICH Code": "8.2.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Protocol Signature Page",
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "85",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.03",
        "Artifact Location": [],
        "Artifact name": "Protocol Amendment Signature Page",
        "Artifact name in v1.3 EDM Reference Model": "Signature Page (Protocol component)",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document investigator and sponsor agreement to the protocol amendment.",
        "ICH Code": "8.2.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Protocol Amendment Signature Page",
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "86",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.04",
        "Artifact Location": [],
        "Artifact name": "Principal Investigator Curriculum Vitae",
        "Artifact name in v1.3 EDM Reference Model": "Investigator CVs",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document qualifications and eligibility of the Principal Investigator to conduct trial and/or provide medical supervision of subjects. To include updates, one-page CVs and biographical sketches.",
        "ICH Code": [
          "8.2.10",
          "8.3.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Principal Investigator Affiliation Form",
          "Principal Investigator Biographical Sketch",
          "Principal Investigator Curriculum Vitae"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "87",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.05",
        "Artifact Location": [],
        "Artifact name": "Sub-Investigator Curriculum Vitae",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document qualifications and eligibility of any sub-Investigators to conduct trial and/or provide medical supervision of subjects. Sub-Investigators include any individual member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical study trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). To include updates, one-page CVs and biographical sketches",
        "ICH Code": [
          "8.2.10",
          "8.3.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Sub-Investigator Affiliation Form",
          "Sub-Investigator Biographical Sketch",
          "Sub-Investigator Curriculum Vitae"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "88",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.06",
        "Artifact Location": [],
        "Artifact name": "Other Curriculum Vitae",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document qualifications and eligibility of site personnel other than the Principal Investigator or Sub-Investigators to conduct trial and/or provide medical supervision of subjects.",
        "ICH Code": "8.2.10",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Other Affiliation Form",
          "Other Biographical Sketch",
          "Other Curriculum Vitae"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "89",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.07",
        "Artifact Location": [],
        "Artifact name": "Site Staff Qualification Supporting Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document site staff qualifications not previously outlined on CVs. May include list of studies, publications, training certificates for specific examinations, ICH-GCP training, site GCP or trial licensure, medical licenses, Human Subjects Protection Training, etc.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "DEA License",
          "Evidence of Registration",
          "ICH-GCP Evidence of Training",
          "IATA Certification",
          "Medical License",
          "Medical Qualification",
          "Professional License",
          "Site Staff Qualification Supporting Information"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Effective Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "90",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.08",
        "Artifact Location": [],
        "Artifact name": "Form FDA 1572",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "For IND trial, 1572 must be completed globally for FDA submission.",
        "ICH Code": "8.2.6",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Form FDA 1572",
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "NO"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "91",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.09",
        "Artifact Location": [],
        "Artifact name": "Investigator Regulatory Agreement",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "A regulatory statement from the investigator required by certain health authorities e.g. includes but is not limited to Qualified Investigator Undertaking form and Clinical Trial Site Information form required by Health Canada.",
        "ICH Code": "8.2.6",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Clinical Trial Site Information Form",
          "Investigator Regulatory Agreement",
          "Qualified Investigator Undertaking Form"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "92",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.10",
        "Artifact Location": [],
        "Artifact name": "Financial Disclosure Form",
        "Artifact name in v1.3 EDM Reference Model": "Financial Disclosure Information",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document financial disclosures, certification documentation and conflicts of interest, which include but are not limited to: completed disclosure forms of financial interests and arrangements of clinical investigators (e.g. FDA Form 3455/3454, NIH COI , clinical investigator financial certification (Canada))",
        "ICH Code": "8.2.4",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Financial Disclosure Form",
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "93",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.11",
        "Artifact Location": [],
        "Artifact name": "Data Privacy Agreement",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document agreement between sponsor and Site Staff (e.g., national or regional data privacy requirements); often contained in Clinical Trial Agreement",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Privacy Agreement",
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "94",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.12",
        "Artifact Location": [],
        "Artifact name": "Clinical Trial Agreement",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document agreement of trial requirements between sponsor or 3rd Party and site/ PI. Includes indemnity unless separate document created.",
        "ICH Code": [
          "8.2.4",
          "8.2.6"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Clinical Trial Agreement",
          "Clinical Trial Agreement with Investigator",
          "Clinical Trial Agreement with Investigator and Site",
          "Clinical Trial Agreement with Site",
          "Termination Agreement"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "95",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.13",
        "Artifact Location": [],
        "Artifact name": "Indemnity",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide legal protection \"as required by country regulations\" in the event of an unforeseen adverse circumstance arising during the course of a clinical trial. May be in Clinical Trial Agreement",
        "ICH Code": [
          "8.2.4",
          "8.2.6"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Indemnity",
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Effective Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "96",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.14",
        "Artifact Location": [],
        "Artifact name": "Other Financial Agreement",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document agreement of trial requirements between other parties involved in the conduct of the trial. Includes indemnity unless separate document created.",
        "ICH Code": [
          "8.2.4",
          "8.2.6"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Supplies",
          "Process Number": "6"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Laboratory Agreement",
          "Other Financial Agreement",
          "Pharmacy Agreement"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "97",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.17",
        "Artifact Location": [],
        "Artifact name": "IP Site Release Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document approval for sites to receive drug supply / investigational product.",
        "ICH Code": "5.14.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IP Site Release Checklist",
          "IP Site Release Documentation",
          "IP Site Release Notification"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "100",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.18",
        "Artifact Location": [],
        "Artifact name": "Site Signature Sheet",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document delegation by the Principal Investigator of trial specific tasks to site personnel conducting the trial.",
        "ICH Code": [
          "4.1.5",
          "8.3.24"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Delegation of Authority Log",
          "Site Signature Sheet"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "101",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.19",
        "Artifact Location": [],
        "Artifact name": "Investigators Agreement (Device)",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Non-financial agreement between the sponsor and the investigator documenting the various responsibilities, as outlined in CFR Title 21 part 812 as well as ICH-E6 (if applicable), in which the investigator will comply.",
        "ICH Code": "812.43c",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Investigators Agreement (Device)",
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "NO"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "240",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.02.20",
        "Artifact Location": [],
        "Artifact name": "Coordinating Investigator Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation to show the approval of a coordinating investigator for a specific region or group of investigators that is not already captured as another artifact for that investigator. Documentation related to a Country's National Coordinator when they are not participating as an Investigator in the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Committees",
          "Process Number": "10"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Coordinating Investigator Clinical Trial Agreement",
          "Coordinating Investigator Confidentiality Agreement",
          "Coordinating Investigator Curriculum Vitae",
          "Coordinating Investigator Documentation",
          "Coordinating Investigator Financial Disclosure Form",
          "Coordinating Investigator GCP Training",
          "Coordinating Investigator Indemnity",
          "Coordinating Investigator Medical License",
          "Coordinating Investigator Personal Data Consent"
        ],
        "SOP Reference": [],
        "Section #": "5.0199999999999996",
        "Section Name": "Site Set-up",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "255",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.03.01",
        "Artifact Location": [],
        "Artifact name": "Trial Initiation Monitoring Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document that trial procedures were reviewed with the investigator and the trial personnel and confirm the site meets requirements to begin trial participation. trial initiation can be conducted via an Investigator Meeting, visit at the site and/or other contact. May include confirmation letters/emails.",
        "ICH Code": "8.2.20",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Monitor Site(s)",
          "Process Number": "19"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Trial Initiation Monitoring Report",
          "Trial Initiation Visit Confirmation Letter",
          "Trial Initiation Visit Follow Up Letter",
          "Trial Initiation Visit Waiver"
        ],
        "SOP Reference": [],
        "Section #": "5.03",
        "Section Name": "Site Initiation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Visit Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "102",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.03.02",
        "Artifact Location": [],
        "Artifact name": "Site Training Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Training materials used to train the sites. Materials may be related to Electronic Data Capture (EDC), Interactive Response Technology (IRT), Rater training. (Also includes training done after site initiation)",
        "ICH Code": "4.1.1",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Site Training Material",
        "SOP Reference": [],
        "Section #": "5.03",
        "Section Name": "Site Initiation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "103",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.03.03",
        "Artifact Location": [],
        "Artifact name": "Site Evidence of Training",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document completion of site training by relevant site personnel. Documentation includes attendance and certification for training delivered which may include Electronic Data Capture (EDC), Interactive Response Technology (IRT), Rater training, etc.",
        "ICH Code": "4.1.1",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Site Evidence of Training",
          "Site Training Attendance Sheet",
          "Site Training Certificate"
        ],
        "SOP Reference": [],
        "Section #": "5.03",
        "Section Name": "Site Initiation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Training Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment"
        },
        "Translation Required": [],
        "Unique ID Number": "104",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.01",
        "Artifact Location": [],
        "Artifact name": "Subject Log",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To anonymously list all subjects including screened, screen failures and enrolled for the sponsor. Not anonymous at the Investigator site",
        "ICH Code": [
          "8.3.20",
          "8.3.22"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Recruit Subjects & Obtain Consent",
          "Process Number": "17"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Subject Consenting Tracker",
          "Subject Enrollment Log",
          "Subject Log",
          "Subject Screening Log",
          "Subject Visit Log"
        ],
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "105",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.02",
        "Artifact Location": [],
        "Artifact name": "Source Data Verification",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document source data and associated verification activity",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Source Data Specification and Agreement",
          "Source Data Verification"
        ],
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "106",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.03",
        "Artifact Location": [],
        "Artifact name": "Monitoring Visit Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document site visits, monitoring trial conduct and compliance of the site, may include confirmation letters/emails.",
        "ICH Code": "8.3.10",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Monitor Site(s)",
          "Process Number": "19"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Co-Monitoring Visit Report",
          "Monitoring Visit Confirmation Letter",
          "Monitoring Visit Follow Up Letter",
          "Monitoring Visit Report",
          "Monitoring Visit Waiver"
        ],
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "04 First Monitoring Visit",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Visit Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "107",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.04",
        "Artifact Location": [],
        "Artifact name": "Visit Log",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document monitoring visit dates and attendees.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Monitor Site(s)",
          "Process Number": "19"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Site Visit Log",
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last visit Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "108",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.05",
        "Artifact Location": [],
        "Artifact name": "Additional Monitoring Activity",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document additional monitoring activity such as co-visits and sponsor-specific monitoring activities",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Monitor Site(s)",
          "Process Number": "19"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Additional Monitoring Activity",
          "Non-Routine Visit Report",
          "Non-Routine Visit Report Confirmation Letter",
          "Non-Routine Visit Report Follow Up Letter",
          "Oversight Monitoring Visit Report",
          "Oversight Monitoring Visit Report Confirmation Letter",
          "Oversight Monitoring Visit Report Follow Up Letter",
          "Site Improvement Plan"
        ],
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "109",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.06",
        "Artifact Location": [],
        "Artifact name": "Protocol Deviations",
        "Artifact name in v1.3 EDM Reference Model": "x Protocol Deviation Listing (component of CSR)",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document non-compliance/ deviations to the protocol. This may also be a consolidated list for a country filed at the country level or a consolidated list for the study filed at the study level.",
        "ICH Code": [
          "3.3.8",
          "5.18.4"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Monitor Site(s)",
          "Process Number": "19"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Protocol Deviations",
          "Protocol Deviation Logs",
          "Protocol Deviation Report"
        ],
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "110",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.07",
        "Artifact Location": [],
        "Artifact name": "Financial Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Includes all invoices, receipts, payment summaries relating to the trial",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage Budget",
          "Process Number": "24"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Financial Documentation",
          "Financial Summary Tracker",
          "Invoices",
          "Payments",
          "Receipts"
        ],
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "111",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.08",
        "Artifact Location": [],
        "Artifact name": "Final Trial Close Out Monitoring Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document trial activities are completed for site closure prior to trial completion. may include confirmation letters/emails.",
        "ICH Code": "8.4.5",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Close Site(s) / Close Site",
          "Process Number": "34"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Close Out Visit Confirmation Letter",
          "Close Out Visit Follow-Up Letter",
          "Close Out Visit Waiver",
          "Final Trial Close Out Monitoring Report"
        ],
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Visit Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "112",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.09",
        "Artifact Location": [],
        "Artifact name": "Notification to Investigators of Safety Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": [
          "To assure investigators are promptly notified of all findings (new, important information on serious adverse events and or safety concerns) that could adversely affect the safety of subjects, impact the conduct of the trial or alter their IRB/IEC's approval/favorable opinion to continue the trial.  Notifications may include but are not limited to Safety line listings, SUSARs, CIOMS, MedWatch, Analysis of Similar Events, cover letters and/or country-specific reporting forms.",
          ""
        ],
        "ICH Code": [
          "5.16.2",
          "5.17",
          "8.3.17-18"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
          "Process Number": "28"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Evidence of Safety Information Distribution",
          "Notification to Investigators of Safety Information"
        ],
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Notification Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "113",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.10",
        "Artifact Location": [],
        "Artifact name": "Subject Identification Log",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To fully identify all subjects screened, screen failed and enrolled in the trial, with unique institution identifiers where relevant",
        "ICH Code": [
          "8.3.21",
          "8.4.3"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Recruit Subjects & Obtain Consent",
          "Process Number": "17"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Subject Identification Log",
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "NO"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "NO"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "234",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.11",
        "Artifact Location": [],
        "Artifact name": "Source Data",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document and confirm source data information at the Investigator site (i.e. medical records containing history of subjects).",
        "ICH Code": "8.3.13",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Complete Subject Study Visit",
          "Process Number": "18"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Source Data",
          "Site Level Source Data Worksheets"
        ],
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "NO"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "NO"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "235",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.12",
        "Artifact Location": [],
        "Artifact name": "Monitoring Visit Follow-up Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document site visit follow-up. Could be grouped with monitoring visit reports.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Monitor Site(s)",
          "Process Number": "19"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Monitoring Visit Follow-up Documentation",
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Visit Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "241",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.04.13",
        "Artifact Location": [],
        "Artifact name": "Subject Eligibility Verification Forms and Worksheets",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Eligibility forms for qualification of trial subjects, may include inclusion/exclusion criteria, lab reports, doctor notes and other qualifying data usually used by (site) staff to ensure subjects are eligible, per protocol, for the study.",
        "ICH Code": [
          "8.3.20",
          "8.3.22"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": "Recruit Subjects & Obtain Consent",
          "Process Number": "17"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Subject Eligibility Verification Forms and Worksheets",
        "SOP Reference": [],
        "Section #": "5.04",
        "Section Name": "Site Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "256",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.05.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes. Should not include monitoring visit follow-up letter.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "5.05",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "114",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.05.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "R",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "5.05",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "115",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.05.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Oversee Vendor(s)",
          "Process Number": "25"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "5.05",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "116",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "05.05.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Monitor Site(s)",
          "Process Number": "19"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "5.05",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "117",
        "Wet Ink Signature": [],
        "Zone #": "5",
        "Zone Name": "Site Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.01",
        "Artifact Location": [],
        "Artifact name": "IP Supply Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the following as they pertain to the IP: 1) quantity and packaging of active, placebo and/or if applicable, comparator or rescue supplies needed to fulfill the requirements of the trial protocol over the life of the trial, as well as blinding plan (if applicable) and 2) acceptable storage temperatures and conditions, storage times, reconstitution fluids and procedures and devices for product infusion. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "ICH Code": [
          "2.13",
          "5.13.3 5.14.1"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IP Supply Plan",
          "Placebo Justification Statement"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "118",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.02",
        "Artifact Location": [],
        "Artifact name": "IP Instructions for Handling",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To instruct on how the IP should be handled during transit and stored upon arrival at the distribution center, depot and/or trial site. Should address expectations for adequate and safe receipt, handling, storage, dispensing, retrieval of unused product from subjects and return of unused IP to the sponsor (or their delegate) If appropriate to the trial, includes preparation of the IP leading to administration and administration instructions.",
        "ICH Code": [
          "5.13.2",
          "5.14.3",
          "8.2.14"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Device User Manual",
          "IP Directions for Use",
          "IP Instructions for Handling",
          "IP Manual",
          "Pharmacy Manual"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "119",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.03",
        "Artifact Location": [],
        "Artifact name": "IP Sample Label",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "A sample of each IP label type (for every pack and every language) to be used in the trial; approval status must be clear. All stages of label text development are included within this artifact.",
        "ICH Code": [
          "5.13.1",
          "8.2.13"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IP Master Label",
          "IP Sample Label"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "120",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.04",
        "Artifact Location": [],
        "Artifact name": "IP Shipment Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To record details of the shipment process including approval , requests, dispatch, tracking and receipts to/from a distribution center, depot and/or trial site.",
        "ICH Code": [
          "5.14.4",
          "8.2.15",
          "8.3.8"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Acknowledgement of Receipt",
          "Approval to Ship",
          "Invoice",
          "IP Shipment Documentation",
          "Packaging Order",
          "Shipment Request Form",
          "Temperature (TempTale) Monitoring"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Shipment Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "121",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.05",
        "Artifact Location": [],
        "Artifact name": "IP Accountability Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document records of the allocation of IP to/from a distribution center, depot, trial site and/or site to subject and the reconciliation of IP prior to return to the sponsor.",
        "ICH Code": [
          "5.14.4",
          "8.3.23",
          "8.4.1"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Drug Accountability Log",
          "IP Accountability Documentation"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "122",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.06",
        "Artifact Location": [],
        "Artifact name": "IP Transfer Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the process and approval for the transfer of IP from one depot to another depot and/or from one site to another site (within or across protocols). Examples include sponsor approval for transfer and evidence of consultation with Qualified Person (QP).",
        "ICH Code": "5.14.4 5.14.3",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Evidence of IP Transfer",
          "IP Transfer Documentation",
          "IP Transfer Plan",
          "Notification of IP Transfer"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Transfer Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "123",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.07",
        "Artifact Location": [],
        "Artifact name": "IP Re-labeling Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the plan for the re-labeling process to occur at the distribution center, depot and/or site and confirmation records that the re-labeling occurred.",
        "ICH Code": "5.14.4 5.14.3",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Evidence of IP Relabeling",
          "IP Relabeling Documentation",
          "IP Relabeling Plan",
          "Notification of IP Relabeling"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "124",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.08",
        "Artifact Location": [],
        "Artifact name": "IP Recall Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the plan for the recall process for the IP to occur at a distribution center, depot and/or site; will include confirmation records that the recall occurred.",
        "ICH Code": "5.14.4 5.14.3",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Evidence of Recall",
          "IP Recall Documentation",
          "IP Recall Plan",
          "Notification of IP Recall"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Recall Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "125",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.09",
        "Artifact Location": [],
        "Artifact name": "IP Quality Complaint Form",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document or record an IP quality complaint.",
        "ICH Code": "5.14.4",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Quality Complaint Form",
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Complaint Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "126",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.10",
        "Artifact Location": [],
        "Artifact name": "IP Return Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To record details of returns to/from a distribution center, depot and/or trial site.  Examples include courier documentation and packing/ inventory listing.",
        "ICH Code": [
          "5.14.4",
          "8.2.15",
          "8.3.9"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Close Site(s) / Reconcile Trial Materials",
          "Process Number": "33"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Acknowledgement of Return",
          "IP Return Documentation",
          "IP Return Form"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Return Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "127",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.11",
        "Artifact Location": [],
        "Artifact name": "IP Certificate of Destruction",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the confirmation of destruction of IP at the end of a trial at a distribution center, depot and/or site .",
        "ICH Code": "5.14.4 8.4.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Close Site(s) / Reconcile Trial Materials",
          "Process Number": "33"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IP Certificate of Destruction",
          "IP Destruction Documentation"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Destruction Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "128",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.01.12",
        "Artifact Location": [],
        "Artifact name": "IP Retest and Expiry Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the batch retesting/analyses of IP for a variety of reasons such as stability confirmation and expiry extension",
        "ICH Code": "5.14.5",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Expiry Extension",
          "IP Retest and Expiry Documentation",
          "Stability Confirmation"
        ],
        "SOP Reference": [],
        "Section #": "6.01",
        "Section Name": "IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "242",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.02.01",
        "Artifact Location": [],
        "Artifact name": "QP (Qualified Person) Certification",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To confirm that any IP from another country has been manufactured and checked in accordance with standards of Good Manufacturing Practices (GMP) at least equivalent to those laid down in Directive 91/356/EEC. Documents the technical release documentation including GMP certification and the name / address of the manufacturer.",
        "ICH Code": [
          "2.12",
          "5.13.1"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "QP (Qualified Person) Certification",
        "SOP Reference": [],
        "Section #": "6.02",
        "Section Name": "IP Release Process Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Effective Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "129",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.02.02",
        "Artifact Location": [],
        "Artifact name": "IP Regulatory Release Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the regulatory IP release process.",
        "ICH Code": [
          "2.12",
          "5.14.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Regulatory Release Documentation",
        "SOP Reference": [],
        "Section #": "6.02",
        "Section Name": "IP Release Process Documentation",
        "Site Level Document": "",
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Release Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "130",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.02.03",
        "Artifact Location": [],
        "Artifact name": "IP Verification Statements",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Any certificate, license or other documentation that is required by a specific regulation to verify the quality, source, manufacture, ingredients or other aspect of investigational and/or control product. Examples include TSE certificate, Controlled IP storage, DEA 223 and GMP Manufacturers License.",
        "ICH Code": [
          "8.2.15",
          "8.3.8 5.14.4"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Controlled IP Storage",
          "DEA 223",
          "GMP Certificate",
          "GMP Manufacturers License",
          "GMP Statement",
          "IP Verification Statements",
          "Manufacturing Authorization",
          "TSE Certificate"
        ],
        "SOP Reference": [],
        "Section #": "6.02",
        "Section Name": "IP Release Process Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "131",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.02.04",
        "Artifact Location": [],
        "Artifact name": "Certificate of Analysis",
        "Artifact name in v1.3 EDM Reference Model": "Certificate of Analysis",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document identity, purity and strength of the IP(s) to be used trial, in accordance with the specifications of the IP, including the acceptance limits and the actual results of the tests.",
        "ICH Code": [
          "2.12",
          "5.13.1",
          "8.2.16",
          "8.3.9"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Batch Records",
          "Certificate of Analysis",
          "Certificate of Conformance"
        ],
        "SOP Reference": [],
        "Section #": "6.02",
        "Section Name": "IP Release Process Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "132",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.03.01",
        "Artifact Location": [],
        "Artifact name": "IP Treatment Allocation Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the treatment allocation or device serial numbers for each subject; used if urgent unblinding or code break is needed or when interim or final unblinding occurs.",
        "ICH Code": [
          "5.13.4",
          "8.2.17",
          "8.4.6"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IP Treatment Allocation Documentation",
          "Kit List",
          "Randomization Envelopes",
          "Randomization List"
        ],
        "SOP Reference": [],
        "Section #": "6.03",
        "Section Name": "IP Allocation Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "133",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.03.02",
        "Artifact Location": [],
        "Artifact name": "IP Unblinding Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the plan and procedures to be taken should the action of breaking the blind for an individual subject be urgently needed, or when interim or final unblinding occurs.",
        "ICH Code": [
          "5.13.4",
          "8.2.17"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IP Unblinding Plan",
          "Unblinding Procedure"
        ],
        "SOP Reference": [],
        "Section #": "6.03",
        "Section Name": "IP Allocation Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "134",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.03.03",
        "Artifact Location": [],
        "Artifact name": "IP Treatment Decoding Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the action of breaking the blind for an individual subject, urgently if needed, or when interim or final unblinding occurs. Treatment unblinding may be controlled by interactive response technology (IRT) and or manually using code break envelopes.",
        "ICH Code": [
          "5.13.4",
          "8.4.6"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Break Blind",
          "Process Number": "30"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Emergency Decoding Authorization Document",
          "IP Treatment Decoding Documentation",
          "Treatment Decoding Form"
        ],
        "SOP Reference": [],
        "Section #": "6.03",
        "Section Name": "IP Allocation Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "08 Database Lock"
        },
        "Translation Required": [],
        "Unique ID Number": "135",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.04.01",
        "Artifact Location": [],
        "Artifact name": "IP Storage Condition Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the unique storage conditions of the IP at the sponsor (if sponsor is distributing), distribution center, depot, trial site and in transit, if required by the available stability requirements of the IP.",
        "ICH Code": "5.13.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IP Storage Condition Documentation",
          "Temperature Logs"
        ],
        "SOP Reference": [],
        "Section #": "6.04",
        "Section Name": "Storage",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "136",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.04.02",
        "Artifact Location": [],
        "Artifact name": "IP Storage Condition Excursion Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To record excursions for IP, from the acceptable pre-defined condition range either during transit or storage at a distribution center, depot and/or trial site.",
        "ICH Code": "5.13.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Approval For Use (following temp excursion)",
          "IP Storage Condition Excursion Documentation",
          "TempTale Documentation",
          "Temperature Excursion Form"
        ],
        "SOP Reference": [],
        "Section #": "6.04",
        "Section Name": "Storage",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "137",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.04.03",
        "Artifact Location": [],
        "Artifact name": "Maintenance Logs",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To record activities and times when quality of condition of IP, Non-IP, device and other trial supplies is assessed over period of use and any maintenance performed, including software logs and certificates of calibration.",
        "ICH Code": "5.14.5",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Calibration Certificate",
          "Calibration Log",
          "Maintenance Logs"
        ],
        "SOP Reference": [],
        "Section #": "6.04",
        "Section Name": "Storage",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "243",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.05.01",
        "Artifact Location": [],
        "Artifact name": "Non-IP Supply Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the details and quantity of non-IP supplies needed to fulfill the trial protocol requirements over the life of the trial. May include but is not limited to, supplementary medication, pre-treatment, other prophylactic therapies, drug delivery supplies (IV tubing, syringes, etc.) and measurement tools such as thermometers, respirometers, etc. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "ICH Code": "2.13",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage Non-IP",
          "Process Number": "23"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Non-IP Supply Plan",
        "SOP Reference": [],
        "Section #": "6.05",
        "Section Name": "Non-IP Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "138",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.05.02",
        "Artifact Location": [],
        "Artifact name": "Non-IP Shipment Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To record details of the shipment of non-IP supplies needed to fulfill the trial protocol requirements to a distribution center, depot and/or site.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage Non-IP",
          "Process Number": "23"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Acknowledgement of Receipt",
          "Approval to Ship",
          "Invoice",
          "Non-IP Shipment Documentation",
          "Packaging Order",
          "Shipment Request Form"
        ],
        "SOP Reference": [],
        "Section #": "6.05",
        "Section Name": "Non-IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Shipment Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "139",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.05.03",
        "Artifact Location": [],
        "Artifact name": "Non-IP Return Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To inventory the returns of certain non-IP supplies needed to fulfill the trial protocol requirements to a distribution center, depot and/or site. Examples include courier documentation and packing/ inventory listing.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage Non-IP",
          "Process Number": "23"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Acknowledgement of Return",
          "Non-IP Return Documentation",
          "Non-IP Return Form"
        ],
        "SOP Reference": [],
        "Section #": "6.05",
        "Section Name": "Non-IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Return Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "140",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.05.04",
        "Artifact Location": [],
        "Artifact name": "Non-IP Storage Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the unique storage conditions of the Non-IP supplies at the sponsor (if sponsor is distributing), distribution center, depot, trial site and in transit, if required by the available stability requirements of the non-IP supplies. To record excursions for non-IP supplies, from the acceptable pre-defined condition range either during transit or storage at a distribution center, depot and/or trial site.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage Non-IP",
          "Process Number": "23"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Non-IP Storage Documentation",
          "Non-IP Storage Condition Excursion Documentation"
        ],
        "SOP Reference": [],
        "Section #": "6.05",
        "Section Name": "Non-IP Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "259",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.06.01",
        "Artifact Location": [],
        "Artifact name": "IRT User Requirement Specification",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document end user requirements from design and capabilities of an interactive response technology (IRT) such as Interactive Voice Response System (IVRS) or Interactive Web Response System (IWRS), included but not limited to screening, randomization or drug allocation. May also include technical aspects of the system development.",
        "ICH Code": "5.5.3",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRT User Requirement Specification",
        "SOP Reference": [],
        "Section #": "6.06",
        "Section Name": "Interactive Response Technology",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "141",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.06.02",
        "Artifact Location": [],
        "Artifact name": "IRT Validation Certification",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To confirm the validation status of the interactive response technology (IRT).",
        "ICH Code": "5.5.3",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRT Validation Certification",
        "SOP Reference": [],
        "Section #": "6.06",
        "Section Name": "Interactive Response Technology",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Certification Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "142",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.06.03",
        "Artifact Location": [],
        "Artifact name": "IRT User Acceptance Testing (UAT) Certification",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the acceptability of the series of assessments of the IRT performed by key users of the system that are designed to show that the IRT has been correctly programmed and meets the requirements of the User Requirements Specification (URS). Minimally, the signature page and may include validation or other documentation.",
        "ICH Code": "5.5.3",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IRT UAT Certification",
          "IRT UAT Executed Scripts",
          "IRT UAT Sign Off",
          "IRT User Acceptance Testing (UAT) Certification"
        ],
        "SOP Reference": [],
        "Section #": "6.06",
        "Section Name": "Interactive Response Technology",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Certification Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "143",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.06.04",
        "Artifact Location": [],
        "Artifact name": "IRT User Manual",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide instructions and define the operational instructions for the IRT for the user.",
        "ICH Code": "5.3.3",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IRT Quick Reference Card",
          "IRT User Manual"
        ],
        "SOP Reference": [],
        "Section #": "6.06",
        "Section Name": "Interactive Response Technology",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "144",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.06.05",
        "Artifact Location": [],
        "Artifact name": "IRT User Account Management",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To capture account management details for all users who received access to the system; should include security role, data account granted, date account disabled",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IP",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "IRT User Account Management",
          "Summary of IRT Access Report"
        ],
        "SOP Reference": [],
        "Section #": "6.06",
        "Section Name": "Interactive Response Technology",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "145",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.07.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "6.07",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "146",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.07.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "6.07",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "147",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.07.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "6.07",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "148",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "06.07.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "6.07",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "149",
        "Wet Ink Signature": [],
        "Zone #": "6",
        "Zone Name": "IP and Trial Supplies"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.01.01",
        "Artifact Location": [],
        "Artifact name": "Safety Management Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": [
          "To describe the end-to-end process for the ongoing safety evaluation for the investigational product; includes data to be collected, reporting objectives and processes for a clinical trial. Plan may include but is not limited to: associated documents for quality management, safety database entry specifications and templates and/or coding guidelines.",
          "This artifact may not be trial specific, thus may include a reference to appropriate SOP(s) or program/IP level plans. One example of where this artifact would be expected to be trial-specific is when a CRO performs this function for a single trial."
        ],
        "ICH Code": [
          "2.2",
          "5.16.1"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Reference Safety Information Approval Form",
          "Safety Management Plan",
          "Safety Reporting Plan",
          "Safety Reporting Templates"
        ],
        "SOP Reference": [],
        "Section #": "7.01",
        "Section Name": "Safety Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "150",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.01.02",
        "Artifact Location": [],
        "Artifact name": "Pharmacovigilance Database Line Listing",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": [
          "Listing of trial data for a single study trial used for a variety of safety evaluation of the investigational product purposes (e.g. Serious Adverse Events (SAE) case listings, database line listings, etc.).",
          "This artifact may not be trial specific, thus may include a reference to program/IP level records. One example of where this artifact would be expected to be trial-specific is when a CRO performs this function for a single trial."
        ],
        "ICH Code": [
          "5.16.1",
          "5.17.3"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
          "Process Number": "28"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Annual Safety Report (ASR)",
          "Development Safety Update Report (DSUR)",
          "Pharmacovigilance Database Line Listing"
        ],
        "SOP Reference": [],
        "Section #": "7.01",
        "Section Name": "Safety Documentation",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Report Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "151",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.02.01",
        "Artifact Location": [],
        "Artifact name": "Expedited Safety Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document unexpected serious adverse drug reactions and other safety information; submitted to regulatory authorities and IRBs/IECs.  Submission artifact is located in 03.03.01.",
        "ICH Code": [
          "5.16.2",
          "5.17",
          "8.3.17-18"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
          "Process Number": "28"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Expedited Safety Report",
        "SOP Reference": [],
        "Section #": "7.02",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Report Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "152",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.02.02",
        "Artifact Location": [],
        "Artifact name": "SAE Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To organize critical data around a serious adverse event, adverse event and/or a laboratory abnormality as identified in the protocol. Reports may include, but are not limited to: specific investigator SAE report forms and supporting data, reporter correspondence, associated note-to-files, source documentation, case logs, narratives, case unblinding forms and/or safety database case printouts.",
        "ICH Code": [
          "4.11",
          "8.3.16"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
          "Process Number": "28"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "SAE Report",
        "SOP Reference": [],
        "Section #": "7.02",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Report Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "153",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.02.03",
        "Artifact Location": [],
        "Artifact name": "Pregnancy Report",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To organize critical data around a pregnancy that occurred whilst either the male or the female subject was participating in a clinical trial. Reporting forms and supporting data collected for pregnancy cases and their outcome. Reports may include but are not limited to specific regulatory forms and supporting data, reporter correspondence, associated note-to-files, source documentation, case logs, case unblinding form, narratives and/or safety database case printouts.",
        "ICH Code": [
          "4.11",
          "8.3.16"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
          "Process Number": "28"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Pregnancy Report",
        "SOP Reference": [],
        "Section #": "7.02",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Report Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "x",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "154",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.02.04",
        "Artifact Location": [],
        "Artifact name": "Special Events of Interest",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To organize critical data around a special event of interest, one that is of scientific and medical concern specific to the product or program. Usually requested by or submitted to Regulatory Agencies. Reports may include but are not limited to specific regulatory forms and supporting data, reporter correspondence, associated note-to-files, source documentation, case logs, narratives, case unblinding forms and/or safety database case printouts.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Manage Urgent Safety Measures",
          "Process Number": "29"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Special Events of Interest",
        "SOP Reference": [],
        "Section #": "7.02",
        "Section Name": "Trial Status Reporting",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Report Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "155",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.03.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific, trial specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes. (Does not include program level communications.)",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
          "Process Number": "28"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "7.03",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "156",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.03.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific, trial specific documents developed for the purpose of tracking activities during the course of the trial.  (Does not include program level tracking information.)",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress",
          "Process Number": "21"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "7.03",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "157",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.03.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related, trial specific meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material. (Does not include program level meeting material.)",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress / Manage Subject Risk / Report Safety Issue(s)",
          "Process Number": "21 / 28"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "7.03",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "158",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "07.03.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "7.03",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "159",
        "Wet Ink Signature": [],
        "Zone #": "7",
        "Zone Name": "Safety Reporting"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.01.01",
        "Artifact Location": [],
        "Artifact name": "Certification or Accreditation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document recognition and approval by an authorized accrediting body applying known acceptable standards, that the central or local facility is competent to perform required test(s) and support reliability of results; if applicable.",
        "ICH Code": [
          "8.2.12",
          "8.3.7"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Certification or Accreditation",
          "CAP Certificate",
          "CLIA Certificate",
          "ISO Certification",
          "Other Certification or Accreditation"
        ],
        "SOP Reference": [],
        "Section #": "8.01",
        "Section Name": "Facility Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Effective Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "160",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.01.02",
        "Artifact Location": [],
        "Artifact name": "Laboratory Validation Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document through use of control data that a central or local laboratory can consistently and reproducibly report results that are reliable; may include but is not limited to reporting of calibration and control results for a research test parameter, antibody or pharmacokinetic testing that may be performed by an internal or external central or local laboratory; required if certification or accreditation is not available for the study test method.",
        "ICH Code": [
          "8.2.12",
          "8.3.7"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Laboratory Validation Documentation",
          "Laboratory System Specifications",
          "Laboratory Kit Assembly Specifications"
        ],
        "SOP Reference": [],
        "Section #": "8.01",
        "Section Name": "Facility Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "161",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.01.03",
        "Artifact Location": [],
        "Artifact name": "Laboratory Results Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Summary listings or individual subject reports provided by the central or local laboratory or other testing facility, e.g. results of biochemical testing, histological examination.",
        "ICH Code": [
          "8.2.12",
          "8.3.8"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Complete Subject Study Visit",
          "Process Number": "18"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Biochemical Testing",
          "Imaging Uploads",
          "Independent Rater Data",
          "Laboratory Results Documentation"
        ],
        "SOP Reference": [],
        "Section #": "8.01",
        "Section Name": "Facility Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "162",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.01.04",
        "Artifact Location": [],
        "Artifact name": "Normal Ranges",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To define acceptable limits (where 95% of the population that a central or local facility serves will fall) for comparative interpretation that allow for medical decisions to be made; may be included in User Manual.",
        "ICH Code": [
          "8.2.11",
          "8.3.6"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Feasibility & Site Evaluation",
          "Process Number": "5"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Normal Ranges",
        "SOP Reference": [],
        "Section #": "8.01",
        "Section Name": "Facility Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Effective Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "163",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.01.05",
        "Artifact Location": [],
        "Artifact name": "Manual",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To outline the procedures to be followed in the collection, handling and shipping of samples; may not be available for local facilities.",
        "ICH Code": "8.2.14",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Imaging Manual",
          "Laboratory Manual",
          "Manual",
          "Other Manual"
        ],
        "SOP Reference": [],
        "Section #": "8.01",
        "Section Name": "Facility Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "164",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.01.06",
        "Artifact Location": [],
        "Artifact name": "Supply Import Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide the necessary documentation required per country to allow for importation of supplies (non-drug / IP), may also include biological samples and related test material (kits, etc.)",
        "ICH Code": [
          "8.2.15",
          "8.3.8"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IMP/Device",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Biologic Supply Import",
          "Biosafety Statements",
          "Customs Statements",
          "Proforma Invoices",
          "Secure Handling of Material and Data",
          "Supply Import Documentation",
          "Supply Import Licenses"
        ],
        "SOP Reference": [],
        "Section #": "8.01",
        "Section Name": "Facility Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "165",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.01.07",
        "Artifact Location": [],
        "Artifact name": "Head of Facility Curriculum Vitae",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To verify that the Head of Facility is suitably qualified to lead and oversee the management and reporting of results; may be included with Certification / Accreditation; may be found in the User Manual.",
        "ICH Code": [
          "8.2.12",
          "8.3.7"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Oversee Vendor(s)",
          "Process Number": "25"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Head of Facility Curriculum Vitae",
        "SOP Reference": [],
        "Section #": "8.01",
        "Section Name": "Facility Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "166",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.01.08",
        "Artifact Location": [],
        "Artifact name": "Standardization Methods",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To confirm that two or more central or local facilities can perform the same test / procedure and obtain consistent results; includes but may not be limited to cross-calibration of test methods between assays or facilities or phantom data or bioanalytical assay.",
        "ICH Code": [
          "8.2.12",
          "8.3.7"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Analytical Method Report",
          "Interlaboratory Comparison Testing",
          "Standardization Methods"
        ],
        "SOP Reference": [],
        "Section #": "8.01",
        "Section Name": "Facility Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "167",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.02.01",
        "Artifact Location": [],
        "Artifact name": "Specimen Label",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To capture critical information about the collection of a sample; may include but is not limited to subject ID, date and time of collection, etc.; may be included in User Manual.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Specimen Label",
        "SOP Reference": [],
        "Section #": "8.02",
        "Section Name": "Sample Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "168",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.02.02",
        "Artifact Location": [],
        "Artifact name": "Shipment Records",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide relevant details for samples sent in any one shipment.",
        "ICH Code": [
          "8.2.15",
          "8.3.8"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IMP/Device",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Specimen Shipment Records",
        "SOP Reference": [],
        "Section #": "8.02",
        "Section Name": "Sample Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Shipment Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "169",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.02.03",
        "Artifact Location": [],
        "Artifact name": "Sample Storage Condition Log",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To monitor and track sample storage under the appropriate conditions.",
        "ICH Code": "8.2.14",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Manage IMP/Device",
          "Process Number": "22"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Sample Storage Condition Log",
        "SOP Reference": [],
        "Section #": "8.02",
        "Section Name": "Sample Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "170",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.02.04",
        "Artifact Location": [],
        "Artifact name": "Sample Import or Export Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide the necessary documentation required per country to allow for importation/exportation of samples.",
        "ICH Code": [
          "8.2.15",
          "8.3.8"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Supplies",
          "Process Number": "6"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Sample Import or Export Documentation",
          "Specimen Export Documentation",
          "Specimen Import Documentation"
        ],
        "SOP Reference": [],
        "Section #": "8.02",
        "Section Name": "Sample Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "171",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.02.05",
        "Artifact Location": [],
        "Artifact name": "Record of Retained Samples",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document location and identification of body fluid, tissue samples or genetic samples being held for possible future (re)testing; to include destruction records, when and if this occurs.",
        "ICH Code": "8.3.25",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Biorepository",
          "Destruction Records",
          "Dispatch Form",
          "Inventory From Lab",
          "Record of Retained Samples"
        ],
        "SOP Reference": [],
        "Section #": "8.02",
        "Section Name": "Sample Documentation",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "172",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.03.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "8.0299999999999994",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "173",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.03.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "8.0299999999999994",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "174",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.03.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Supplies",
          "Process Number": "6"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "8.0299999999999994",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "175",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "08.03.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "8.0299999999999994",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "176",
        "Wet Ink Signature": [],
        "Zone #": "8",
        "Zone Name": "Central and Local Testing"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.01.01",
        "Artifact Location": [],
        "Artifact name": "Qualification and Compliance",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To confirm that a third party meets all relevant criteria to fulfill a contractual obligation; may include a quality questionnaire, a visit report to qualify their capabilities, other documents that support capabilities.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Evidence of Third Party Qualification",
          "Third Party Audit Certificate"
        ],
        "SOP Reference": [],
        "Section #": "9.01",
        "Section Name": "Third Party Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "177",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.01.02",
        "Artifact Location": [],
        "Artifact name": "Third Party Curriculum Vitae",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document qualifications and eligibility of Individual Third Party Trial Team Members; CVs, Questionnaires etc. including translators, for the project. Not intended to duplicate records filed in Zones 1 and 5 (sponsor & investigator).",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Third Party Curriculum Vitae",
        "SOP Reference": [],
        "Section #": "9.01",
        "Section Name": "Third Party Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "257",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.01.03",
        "Artifact Location": [],
        "Artifact name": "Ongoing Third Party Oversight",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To confirm throughout the duration of a study that a third party continues to meet all relevant criteria to fulfill a contractual obligation.",
        "ICH Code": "5.2.2",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Ongoing Third Party Oversight",
        "SOP Reference": [],
        "Section #": "9.01",
        "Section Name": "Third Party Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "258",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.02.01",
        "Artifact Location": [],
        "Artifact name": "Confidentiality Agreement",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To confirm by written legal agreement that key information between parties will be prevented from being inappropriately disclosed. May be included in another contractual agreement.",
        "ICH Code": "1.1599999999999999",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Third Party Confidentiality Agreement",
          ""
        ],
        "SOP Reference": [],
        "Section #": "9.02",
        "Section Name": "Third Party Set-up",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "178",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.02.02",
        "Artifact Location": [],
        "Artifact name": "Vendor Selection",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To identify how a third party was selected. May include details of other third parties short-listed, master vendor list and any assessments carried out prior to selection.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / Vendors",
          "Process Number": "8"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Vendor Evaluation",
          "Vendor Decision"
        ],
        "SOP Reference": [],
        "Section #": "9.02",
        "Section Name": "Third Party Set-up",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "179",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.02.03",
        "Artifact Location": [],
        "Artifact name": "Contractual Agreement",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document by a written dated signed agreement between two or more parties that defines any arrangements on delegation and distribution of tasks and obligations (including financial obligations); critical components include service description and budget.",
        "ICH Code": [
          "1.17",
          "8.2.6"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Secure Resources / People",
          "Process Number": "7"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Authorization To Proceed",
          "Budget",
          "Contract",
          "Change Order",
          "Data Privacy Agreements",
          "Indemnification"
        ],
        "SOP Reference": [],
        "Section #": "9.02",
        "Section Name": "Third Party Set-up",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "180",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.03.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Oversee Vendor(s)",
          "Process Number": "25"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "9.0299999999999994",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "182",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.03.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "9.0299999999999994",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "183",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.03.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Oversee Vendor(s)",
          "Process Number": "25"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "9.0299999999999994",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "184",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "09.03.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "9.0299999999999994",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "185",
        "Wet Ink Signature": [],
        "Zone #": "9",
        "Zone Name": "Third parties"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.01.01",
        "Artifact Location": [],
        "Artifact name": "Data Management Plan",
        "Artifact name in v1.3 EDM Reference Model": "Data Management Plan",
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To identify the overall strategy for data management process for the trial; a compilation of documents that may include amendments/appendices but are not limited to: Completion Guidelines, Data Quality Plan, CRF Design Document, Database (build) Specification, Entry Guidelines, Database Testing..",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Management Plan",
        "SOP Reference": [],
        "Section #": "10.01",
        "Section Name": "Data Management Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "186",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.02.01",
        "Artifact Location": [],
        "Artifact name": "CRF Completion Requirements",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide detailed instructions on how data points on each CRF are to be completed; how to enter on paper and if EDC, how to enter data into the system.",
        "ICH Code": [
          "2.10",
          "4.9.1",
          "4.9.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Capture Subject Data",
          "Process Number": "3"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "CRF Completion Requirements",
        "SOP Reference": [],
        "Section #": "10.02",
        "Section Name": "Data Capture",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "187",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.02.02",
        "Artifact Location": [],
        "Artifact name": "Annotated CRF",
        "Artifact name in v1.3 EDM Reference Model": "Annotated CRF",
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To assign variable names and attributes to the fields on the CRF and to link the variables to the tables within the database; may also be used as an aid for database programming on how to structure the database; use for data extraction; may be generated at the time of regulatory submission.",
        "ICH Code": "5.0999999999999996",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Complete Subject Study Visit",
          "Process Number": "18"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Annotated CRF",
          "Annotated CRF Electronic Data Capture",
          "Annotated CRF Study Data Tabulation Model (SDTM)"
        ],
        "SOP Reference": [],
        "Section #": "10.02",
        "Section Name": "Data Capture",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "188",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.02.04",
        "Artifact Location": [],
        "Artifact name": "Documentation of Corrections to Entered Data",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Any documentation used to query database discrepancies and to record approved corrections to the clinical trial database; may include self-evident corrections, global queries, SAE queries, laboratory queries and any other database queries generated.  Additionally, include any agreements per trial and site that trial personnel are permitted to perform without the need to issue a query to the investigator along with acknowledge acceptance/signing of these changes by Investigator.",
        "ICH Code": [
          "4.9.3",
          "8.3.15"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Data Clarification Forms",
          "Data Query Forms",
          "Documentation of Corrections to Entered Data"
        ],
        "SOP Reference": [],
        "Section #": "10.02",
        "Section Name": "Data Capture",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "190",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.02.05",
        "Artifact Location": [],
        "Artifact name": "Final Subject Data",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Final Subject data (EDC/ePRO/Paper) for the protocol and a copy of each site's data by-subject. Associated documents may include but are not limited to documentation of subject data corrections, subject diaries, questionnaires, laboratory reports and other third-party specialty data. Does not include the final study datasets.",
        "ICH Code": [
          "4.9.3",
          "5.5",
          "8.3.14",
          "4.9.4"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Final Subject Data",
          "Site Receipt of Final Subject Data"
        ],
        "SOP Reference": [],
        "Section #": "10.02",
        "Section Name": "Data Capture",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": [],
          "Trial Level MILESTONE/EVENT": []
        },
        "Translation Required": [],
        "Unique ID Number": "191",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.01",
        "Artifact Location": [],
        "Artifact name": "Database  Requirements",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide a detailed design framework for the system(s) used to manage and store subject/patient data captured via a paper CRF or eCRF for the specified trial. Not to be confused with specifications for the Electronic Data Capture (EDC) system (see 10.04.02)",
        "ICH Code": [
          "1.46",
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Capture Subject Data",
          "Process Number": "3"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Database Requirements",
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "192",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.02",
        "Artifact Location": [],
        "Artifact name": "Edit Check Plan",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Specifications which will detect data that is illogical, unexpected, missing, redundant, or is outside of defined study parameters; usually implemented via programming logic",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Edit Check Plan",
          "Edit Check Specifications"
        ],
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "193",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.03",
        "Artifact Location": [],
        "Artifact name": "Edit Check Programming",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "The computer code which satisfies the edit check plan/specification details; may include a reference to where the code resides.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Capture Subject Data",
          "Process Number": "3"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Edit Check Programming",
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "194",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.04",
        "Artifact Location": [],
        "Artifact name": "Edit Check Testing",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide evidence that the data edit checks have been implemented correctly; can include the data used to test the programming logic",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Edit Check Testing",
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "195",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.05",
        "Artifact Location": [],
        "Artifact name": "Approval for Database Activation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Documentation that all database specification requirements have been satisfied and system can go live; will also include confirmation that UAT (user acceptance testing) has been successfully completed. May include a modified version to activate implementation of change control",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Approval for Database Activation",
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Approval Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "196",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.06",
        "Artifact Location": [],
        "Artifact name": "External Data Transfer Specifications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document import and export data specifications; includes but is not limited to diary, lab, IVRS, imaging; integration from external systems to database and may include transfer from one group to another.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "External Data Transfer Authorization",
          "External Data Transfer Specifications",
          "External Data Transfer Testing Documentation"
        ],
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "197",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.07",
        "Artifact Location": [],
        "Artifact name": "Data Entry Guidelines (Paper)",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To provide detailed instructions on how CRF data is to be entered into a database; specific to a paper CRF trial (therefore, would not be required with an EDC trial).",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Capture Subject Data",
          "Process Number": "3"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Entry Guidelines (Paper)",
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "198",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.08",
        "Artifact Location": [],
        "Artifact name": "SAE Reconciliation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document reconciliation and resolution of discrepancies between the SAEs in the safety and the clinical databases has been successfully completed.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "SAE Reconciliation",
          "SAE Reconciliation Approval",
          "SAE Reconciliation Report"
        ],
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "199",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.09",
        "Artifact Location": [],
        "Artifact name": "Dictionary Coding",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the tools used in medical coding and the final coded terms; includes medical sign off of coding; may include resolution discrepancies.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Dictionary Coding",
          "Medical Coding Approval",
          "Medical Coding Consistency Report",
          "Medical Coding Guidelines"
        ],
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "200",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.10",
        "Artifact Location": [],
        "Artifact name": "Data Review Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the procedures for creating and implementing a Quality Control (QC) Plan or Data Review Plan to ensure that quality data is captured into a clinical database on an ongoing basis. Artifact can include any evidence of the results from the plan.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Data Review Documentation",
          "Data Review Plan",
          "Data Validation Plan",
          "DB Audit Specification",
          "Third Party Vendor Reconciliation Report"
        ],
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "201",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.11",
        "Artifact Location": [],
        "Artifact name": "Database Lock and Unlock Approval",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Confirmation that all of the requirements for database release have been meet; may include all unlock and re-lock documentation as well as a report on data quality issues and summary of essential activities prior to database lock",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Database Interim Lock Approval",
          "Database Lock and Approval",
          "Database Lock and Unlock Approval",
          "Database Unlock Approval"
        ],
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Approval Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "08 Database Lock"
        },
        "Translation Required": [],
        "Unique ID Number": "202",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.03.12",
        "Artifact Location": [],
        "Artifact name": "Database Change Control",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Summary of requested change, reason for change, relevant approvals, impact / risk analysis, associated requirements, specifications and other documentation describing the validation and implementation of this change.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Database Change Control",
          "Data Model Difference Report",
          "Database Modification Approval"
        ],
        "SOP Reference": [],
        "Section #": "10.029999999999999",
        "Section Name": "Database",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Change Control Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "244",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.04.01",
        "Artifact Location": [],
        "Artifact name": "System Account Management",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To capture account management details for all users who received access to the system (e.g.: ePRO, eCRF); intended to include users' security role, date account granted, date account disabled.",
        "ICH Code": "5.5.3 (d) and (e)",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "EDC User Authorization Documentation",
          "EDC User Report",
          "Electronic Signature Authorization Form",
          "System Account Management"
        ],
        "SOP Reference": [],
        "Section #": "10.039999999999999",
        "Section Name": "EDC Management",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "204",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.04.02",
        "Artifact Location": [],
        "Artifact name": "Technical Design Document",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "A technical planning and tracking document containing all the elements required to build and test the EDC application including the variables to be collected, their logical arrangement, navigation between the different forms, and the checks for logical consistency. May take the form of a spreadsheet created manually by a programmer and uploaded to the EDC application (e.g. to generate the eCRF or ePRO system), or exported from the application after building as a record of its technical design. May include some code for 10.03.03, Edit Check Programming.",
        "ICH Code": "5.5.3",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Technical Design Document",
        "SOP Reference": [],
        "Section #": "10.039999999999999",
        "Section Name": "EDC Management",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "245",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.04.03",
        "Artifact Location": [],
        "Artifact name": "Validation Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Documents establishing the project context and documentation requirements for EDC (e.g.: eCRF or ePRO); can include the plan for and results of, the user acceptance testing (UAT). Includes the validation report to provide wrap up and post go-live summary if required.",
        "ICH Code": [
          "5.5.1",
          "5.5.3"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Set up site(s)",
          "Process Number": "16"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Validation Certificate",
          "Validation Executed Scripts",
          "Validation  Plan",
          "Validation Report",
          "Other Validation Documents"
        ],
        "SOP Reference": [],
        "Section #": "10.039999999999999",
        "Section Name": "EDC Management",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "246",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.05.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "10.05",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "205",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.05.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "10.05",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "206",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.05.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "10.05",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "207",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "10.05.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "10.05",
        "Section Name": "General",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "208",
        "Wet Ink Signature": [],
        "Zone #": "10",
        "Zone Name": "Data Management"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.01.01",
        "Artifact Location": [],
        "Artifact name": "Statistical Analysis Plan",
        "Artifact name in v1.3 EDM Reference Model": "Statistical Analysis Plan",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the statistical aspects of the trial design, the process of data selection for all analyzes, the data items to be analyzed and all the procedures and methods to be employed in the analysis of those data items as well as the planned presentation of those results (Tables, Listings and Figures (TLFs), all versions of the SAP and approval forms). Includes interim and final.",
        "ICH Code": "6.9",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Analysis Convention Document",
          "Interim Analysis SAP",
          "SAP Approval",
          "SPP Approval",
          "Statistical Analysis Plan (SAP)",
          "Statistical Programming Plan (SPP)"
        ],
        "SOP Reference": [],
        "Section #": "11.01",
        "Section Name": "Statistics Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment"
        },
        "Translation Required": [],
        "Unique ID Number": "209",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.01.02",
        "Artifact Location": [],
        "Artifact name": "Sample Size Calculation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the technique, assumptions and output used to calculate the sample size; can include QC and sign off.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Sample Size Calculation",
          "Sample Size Validation"
        ],
        "SOP Reference": [],
        "Section #": "11.01",
        "Section Name": "Statistics Oversight",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "01 First Country RA Approval"
        },
        "Translation Required": [],
        "Unique ID Number": "210",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.02.01",
        "Artifact Location": [],
        "Artifact name": "Randomization Plan",
        "Artifact name in v1.3 EDM Reference Model": "Randomization Scheme",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To describe the randomization scheme (e.g. number and name of treatments, strata, block size) and how the randomization will be carried out; this plan is then used to initiate programming.",
        "ICH Code": [
          "4.7",
          "6.4.2"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Randomization Plan",
        "SOP Reference": [],
        "Section #": "11.02",
        "Section Name": "Randomization",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment"
        },
        "Translation Required": [],
        "Unique ID Number": "211",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.02.02",
        "Artifact Location": [],
        "Artifact name": "Randomization Procedure",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To define the actual steps for how subjects are randomized in a trial. This could be by interactive response technology (IRT)/IVRS, or a manual process ((i.e. work instruction). May be part of the randomization plan.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Randomization Procedure",
          "Randomization Specification"
        ],
        "SOP Reference": [],
        "Section #": "11.02",
        "Section Name": "Randomization",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment"
        },
        "Translation Required": [],
        "Unique ID Number": "212",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.02.03",
        "Artifact Location": [],
        "Artifact name": "Master Randomization List",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Current Artifact Name": [],
        "Definition / Purpose": "The single source on the assignment of subjects to protocol specified groups.  In blinded studies, this list remains blinded until its release following the final data lock.",
        "ICH Code": "8.2.18",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Master Randomization List",
        "SOP Reference": [],
        "Section #": "11.02",
        "Section Name": "Randomization",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "213",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.02.04",
        "Artifact Location": [],
        "Artifact name": "Randomization Programming",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Computer code to generate randomization number for treatment assignment.",
        "ICH Code": "5.4.1",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Randomization Programming",
        "SOP Reference": [],
        "Section #": "11.02",
        "Section Name": "Randomization",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "214",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.02.05",
        "Artifact Location": [],
        "Artifact name": "Randomization Sign Off",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To verify that the randomization program generates the randomization number and treatment assignment correctly according to the randomization schema specified for the trial.",
        "ICH Code": "5.1.1",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Randomization Sign Off",
        "SOP Reference": [],
        "Section #": "11.02",
        "Section Name": "Randomization",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready"
        },
        "Translation Required": [],
        "Unique ID Number": "215",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.02.06",
        "Artifact Location": [],
        "Artifact name": "End of Trial or Interim Unblinding",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document and authorize the release of the randomization code and allow the trial data to be unblinded. Includes evidence of release of end of trial unblinding. May include a request for partial unblinding, or to open the randomization list for maintenance by randomization management personnel.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Subject Risk / Break Blind",
          "Process Number": "30"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Administrative Interim Unblinding Request Form",
          "End of Trial or Interim Unblinding",
          "Results Release Authorization Memorandum"
        ],
        "SOP Reference": [],
        "Section #": "11.02",
        "Section Name": "Randomization",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Signature Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "X",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "216",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.01",
        "Artifact Location": [],
        "Artifact name": "Data Definitions for Analysis Datasets",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To define the programming logic required to transform the raw dataset to the analysis dataset; includes populations, etc.; as outlined in the SAP.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Definitions for Analysis Datasets",
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "217",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.02",
        "Artifact Location": [],
        "Artifact name": "Analysis QC Documentation",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To confirm the QC procedures for analysis programs and validation of analysis QC programs, as well as the actual output of the QC steps.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Trial Management Strategy",
          "Process Number": "12"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Analysis QC Documentation",
          "Validation Documentation Approval",
          "Validation Plan",
          "Validation Report"
        ],
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "218",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.03",
        "Artifact Location": [],
        "Artifact name": "Interim Analysis Raw Datasets",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "The export of raw data for interim analysis purposes. This may include CDISC datasets such as Operational Data Model (ODM) or SDTM.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Interim Data Analysis",
          "Process Number": "36"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Interim Analysis Raw Datasets",
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "File Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "219",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.04",
        "Artifact Location": [],
        "Artifact name": "Interim Analysis Programs",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "The suite of programs designed to generate the interim analysis outputs as referenced in the SAP.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Interim Analysis Programs",
          "Interim Analysis Datasets Programs",
          "Interim Analysis Macros"
        ],
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "File Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "220",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.05",
        "Artifact Location": [],
        "Artifact name": "Interim Analysis Datasets",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "The datasets used for the interim analyses.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Interim Data Analysis",
          "Process Number": "36"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Interim Analysis Datasets",
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "File Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "221",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.06",
        "Artifact Location": [],
        "Artifact name": "Interim Analysis Output",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "The Tables Listings and Figures produced from the interim analysis datasets; includes Statistics approval.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Interim Data Analysis",
          "Process Number": "36"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Interim Analysis Graphs",
          "Interim Analysis Figures",
          "Interim Analysis Listings",
          "Interim Analysis Statistics Approval",
          "Interim Analysis Tables"
        ],
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "222",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.07",
        "Artifact Location": [],
        "Artifact name": "Final Analysis Raw Datasets",
        "Artifact name in v1.3 EDM Reference Model": "Datasets",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "The export of raw data for final analysis purposes. This may include CDISC datasets such as Operational Data Model (ODM), SDTM or case report tabulation (CRT) package",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Final Data Analysis",
          "Process Number": "37"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Final Analysis Raw Datasets",
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "File Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "223",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.08",
        "Artifact Location": [],
        "Artifact name": "Final Analysis Programs",
        "Artifact name in v1.3 EDM Reference Model": "Program File for Analysis Dataset",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "The suite of programs designed to generate the final analysis outputs as referenced in the SAP.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Develop Study Design / Document Development",
          "Process Number": "4"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Final Analysis Datasets Programs",
          "Final Analysis Macros",
          "Final Analysis Programs"
        ],
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "File Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "224",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.09",
        "Artifact Location": [],
        "Artifact name": "Final Analysis Datasets",
        "Artifact name in v1.3 EDM Reference Model": "Analysis Datasets",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "The datasets used for the final analysis/case report tabulation (CRT) package. If required, study-level submission datasets can be filed here.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Final Data Analysis",
          "Process Number": "37"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Final Analysis Datasets",
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "File Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "225",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.10",
        "Artifact Location": [],
        "Artifact name": "Final Analysis Output",
        "Artifact name in v1.3 EDM Reference Model": "Statistical Output",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "The Tables, Listings and Figures produced from the final analysis datasets; includes Statistics approval. May be appended to the CSR.",
        "ICH Code": [
          "5.22",
          "8.4.8"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Final Data Analysis",
          "Process Number": "37"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Final Analysis Graphs",
          "Final Analysis Figures",
          "Final Analysis Listings",
          "Final Analysis Statistics Approval",
          "Final Analysis Tables"
        ],
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Document Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "226",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.03.11",
        "Artifact Location": [],
        "Artifact name": "Subject Evaluability Criteria and Subject Classification",
        "Artifact name in v1.3 EDM Reference Model": "Protocol Deviation Listing",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document the decisions which define the criteriaapplied to evaluate each subject in the trial, in order to that will unambiguously assign the subject to the populations established in the SAP.",
        "ICH Code": "6.9.7",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "M",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Interim Data Analysis",
          "Process Number": "36"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Final Protocol Deviation Report",
          "Population Definition Criteria",
          "Protocol Deviation Listing",
          "Subject Evaluability Criteria and Subject Classification"
        ],
        "SOP Reference": [],
        "Section #": "11.03",
        "Section Name": "Analysis",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Version Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "08 Database Lock"
        },
        "Translation Required": [],
        "Unique ID Number": "227",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.04.01",
        "Artifact Location": [],
        "Artifact name": "Interim Statistical Report(s)",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To summarize the relevant statistical aspects of the interim analysis. May be appended to the CSR.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Report Data / Write Reports",
          "Process Number": "40"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Interim Statistical Report(s)",
        "SOP Reference": [],
        "Section #": "11.04",
        "Section Name": "Report",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Report Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "05 Significant Study Event"
        },
        "Translation Required": [],
        "Unique ID Number": "228",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.04.02",
        "Artifact Location": [],
        "Artifact name": "Statistical Report",
        "Artifact name in v1.3 EDM Reference Model": "Statistical Report",
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To summarize the relevant statistical aspects of the final analysis. May be appended to the CSR.",
        "ICH Code": [
          "5.1",
          "5.5"
        ],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Final Data Analysis",
          "Process Number": "37"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Statistical Report",
        "SOP Reference": [],
        "Section #": "11.04",
        "Section Name": "Report",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Report Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved"
        },
        "Translation Required": [],
        "Unique ID Number": "229",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.05.01",
        "Artifact Location": [],
        "Artifact name": "Relevant Communications",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "ICH Code": "8.3.11",
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": [],
          "Process Number": "Per content"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "SOP Reference": [],
        "Section #": "11.05",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Correspondence Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "230",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.05.02",
        "Artifact Location": [],
        "Artifact name": "Tracking Information",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Recommended",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project / Report on Progress",
          "Process Number": "21"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "SOP Reference": [],
        "Section #": "11.05",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Last Entry Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "231",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.05.03",
        "Artifact Location": [],
        "Artifact name": "Meeting Material",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Analyze Data / Final Data Analysis",
          "Process Number": "37"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": [
          "Agenda",
          "Attendance Sheet",
          "Minutes",
          "Presentation Materials"
        ],
        "SOP Reference": [],
        "Section #": "11.05",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Meeting Start Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "232",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      },
      {
        "Additional Metadata": [],
        "Artifact #": "11.05.04",
        "Artifact Location": [],
        "Artifact name": "Filenote",
        "Artifact name in v1.3 EDM Reference Model": [],
        "Core or Recommended for inclusion": "Core",
        "Country Level MILESTONE/EVENT": [],
        "Country/ Region Level Document": [],
        "Current Artifact Name": [],
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "ICH Code": [],
        "Investigator Initiated Study Artifacts M: mandatory, D: dependent upon the type of study, R: recommended": "D",
        "Process Based Metadata": {
          "Process Name": "Manage Project",
          "Process Number": "20"
        },
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "SOP Reference": [],
        "Section #": "11.05",
        "Section Name": "General",
        "Site Level Document": [],
        "Site Level MILESTONE/EVENT": [],
        "Suggested Columns for Implementing the TMF Reference Model": {
          "Artifact Owner": [],
          "Dating Convention": "Filenote Date"
        },
        "TMF Artifacts (Device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Artifacts (Non-device) ": {
          "Investigator Document": "NO",
          "Sponsor Document": "X"
        },
        "TMF Level": {
          "Trial Level Document": "X",
          "Trial Level MILESTONE/EVENT": "11 Ongoing"
        },
        "Translation Required": [],
        "Unique ID Number": "233",
        "Wet Ink Signature": [],
        "Zone #": "11",
        "Zone Name": "Statistics"
      }
    ]
  },
  "glossary": {
    "IRB": "Institutional Review Board",
    "TSE": "Transmissible Spongiform Encephalopathy",
    "08 - Central and Local Testing": "Records related to all specialty testing vendors, including central and local laboratories, on a global study level, a country level or a site level. Records include certification (and expiration dates), procedure manuals, current normal value ranges and the test facility staff curriculum vitae (CV). The content should be modified based on the testing utilized.",
    "Artifact": "Records or documents which one would expect to find in a TMF, at both Sponsor and Investigator site.  It is important to note that artifact \"progeny records\" such as approval/signature pages, amended records or translation documentation are not typically called out uniquely as they belong filed with their related artifact.",
    "Q&A": "Questions and Answers",
    "IB": "Investigator Brochure",
    "SOP": "Standard Operating Procedure",
    "ICH": "International Committee on Harmonization",
    "SAP": "Statistical Analysis Plan",
    "MRI": "Magnetic Resonance Imaging",
    "CDISC": "Clinical Data Interchange Standards Consortium",
    "GCP": "Good Clinical Practice",
    "IIS": "For IIS, M is Mandatory, D is dependant upon the type of study being undertaken, R is recommended",
    "IVRS": "Interactive Voice Randomization System",
    "IDE": "Investigational Device Exemption",
    "06 - IP and Trial Supplies": "Records related to the products under investigation including comparators - including instructions for shipping, storage, handling, returns and destruction, regulatory requirements, certificates, treatment allocation and decoding, inventory information - also includes supplies needed to fulfill the trial protocol requirements including shipping and returns  and any relevant communications.",
    "Core": "If created or collected, the artifact must be in the TMF as dictated by either the ICH Guidelines, regulations, or by consensus of the TMF Reference Model group.",
    "IWRS": "Interactive Web Randomization System",
    "UAT": "User Acceptance Testing",
    "07 - Safety Reporting": "Records related to trial-specific Safety and Pharmacovigilance management:  This includes the safety management plan, safety database line listings, safety reports, and non-submission communications/documentation",
    "Drafts": "Drafts to be excluded unless specifically submitted for approval",
    "PI": "Principal Investigator",
    "ISF": "X refers to an artifact that is always part of the ISF; NO refers to one that usually is not - please note there may be some targeted exceptions based on local criteria (i.e. countries).",
    "Sub I": "Sub Investigator",
    "Paper TMF / eTMF": "Paper TMF usually presented according to Trial, Country and Site levels. Electronic TMFs denote level using metadata. For single country, combine Trial and Country.",
    "URS": "User Requirement Specifications",
    "NIH COI": "National Institute of Health Conflict of Interest",
    "Alternate Name": "A term equivalent to the Artifact Name, that may be commonly known in different facets or geographies of the clinical development industry.",
    "CSR": "Clinical Study Report",
    "IRT": "Interactive Response Technology",
    "IMPD": "Investigational Medicinal Product Dossier",
    "EU": "European Union",
    "CRF": "Case Report Form",
    "QP": "Qualified Person",
    "02 - Central Trial Documents": "Includes the IB, Protocol, and Amendments, Sample CRF, ICF, and the CSR, as well as any ancillary documents directly related to the above. Capture study documents that are related to the protocol, key subject documentation such as the ICF, questionnaire, diary, participation card and clinical study reports including pharmacokinetics in accordance with applicable regulatory standards",
    "SDTM": "Study Data Tabular Module",
    "xEVMPD": "Extended EudraVigilance Medicinal Product Dictionary",
    "SUSAR": "Suspected Unexpected Serious Adverse Reaction",
    "Combining / Dividing": "Any artifacts can be combined as per Sponsor requirements. Should a sponsor require more specificity, rather than dividing an artifact, use the Subartifacts concept introduced in v3.0 of the model to identify the appropriate place for your company's record types.",
    "TLF": "Tables, Listings & Figures",
    "QC": "Quality Control",
    "05 - Site Management": "Records related to selection, setup and management of investigational sites. Includes central site training and central monitor training. In addition, documentation related to unselected sites. At the trial or country level, this section pertains to multi-site records and communications, such as newsletters, all-sites communications, etc. Site specific details will be managed in the Investigator Site Specific File.",
    "09 - Third Parties": "Records related to the establishment and maintenance of a relationship between Sponsors and the Vendors / 3rd-Parties serving Sponsors by contract on the study. (ex, delegation of responsibilities)",
    "Central and Local Testing": "Centralized and local testing zone is intended for all specialty testing vendors, on a global study level, a country level or a site level and should be modified based on the testing utilized.",
    "IDMC": "Independent Data Monitoring Committee",
    "IP": "Investigational Product",
    "Recommended": "The artifact does not have to be produced, but if it is created or collected, it is required to be in the TMF if not housed elsewhere.",
    "CTA": "Clinical Trial Application",
    "SAE": "Serious Adverse Event",
    "04 - IRB / IEC and other Approvals": "Official communications and exchanges with IRBs/IECs, including central, national, regional and local. Includes records related to IRB/IEC submissions, approvals, acknowledgments, as well as oversight information about the IRB/IEC.",
    "USADE": "Unexpected Serious Adverse Device Events",
    "IV": "Intra venous",
    "ePRO": "Electronic Patient Reported Outcomes",
    "TMF": "Trial Master File",
    "Sub-artifact": "When an artifact name does not explicitly refer to a single kind of record (Trial Management Plan, e.g.), sub-artifacts are intended to provide a means to list all company-specific records that a company would expect to file under a given artifact. Examples are provided in the model but expected to be overridden as part of adopting the Reference Model for your company.",
    "PK": "Pharmacokinetic",
    "CoC": "Change of Control",
    "01 - Trial Management": "Records related to the general design, management and oversight of the study; includes information about the trial team; project management and tracking; committees and charters, and training.",
    "eCRF": "Electronic Case Report Form",
    "IND": "Investigational New Drug Application",
    "FDA": "Food and Drug Administration",
    "CRO": "Contract Research Organization",
    "EDC": "Electronic Data Capture",
    "GMP": "Good Manufacturing Practice",
    "ODM": "Operational Data Model",
    "03 - Regulatory": "Records related to Regulatory Submissions and Approvals (to/from Health Authorities), Regulatory Filing and Registration Information, and Regulatory Notifications specific to the clinical trial.",
    "IEC": "Institutional Ethics Committee",
    "DSMB": "Data Safety Monitoring Board",
    "ID": "Identification",
    "11 - Statistics": "Records related to Biostatistics and Statistical Programming activity on the study.",
    "10 - Data Management": "Records related to Data Management activity on the study. Includes subject data (completed CRFs or Final EDC Data). Database definition",
    "DEA": "Drug Enforcement Administration",
    "CV": "Curriculum Vitae",
    "CIOMS": "Council for International Organizations of Medical Sciences"
  }
}